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SUMMARY 
A technique for inicroinjecting individual paramecium cells 
with small volumes of liquid has been developed. Using this technique 
it was shown that cytoplasmically inherited erythromycin resistance 
Lo 0fjA. 
in Paramecium aurelia was4ra&t in the mitochondria, probably on 
the mitochondrial DNA. The transmission of this erythromycin 
resistance by microinjection kas shown to be completely removed 
by low concentrations of non ionic detergent while remaining 
unaffected by DNAse or RNAse. 
Preliminary evidence is presented concerned with the number 
of mitochondria required to transmit erythromycin resistance to a 
sensitive cell. A statistical analysis of these results suggests 
that only one or two mitochondria may be sufficient t, transfer 
resistance. 
The effect of erythromycin on the mitochor*ial morphology 
of both sensitive and resistant cells was studied. Electron micro-
graphs of cells exposed to erythromycin for various lengths of time 
showed that the antibiotic has striking effects on mitochondrial 
structure: the cristae were lost progressively with time of exposure 
and new structures were seen to develop. 
The change from sensitivity to erythromycin resistance 
following microinjection was studied by electronmicroscopç 
observations of individually fixed cells. The existence of two 
ii. 
distinct classes of mitochondria in these transforming cells 
suggests that mitochondria are autonomous with respect to erythro-
mycin resistance. This evidence implies that erythromycin resistance 
is acquired by direct selection for the newly Látroduced "resistant" 
mitochondria. 
Erythromycin resistant mitochondria have been transferred 
by microinjection between three different syngens of Paramecium aurelia. 
It was found that the proportion of cells developing resistance in 
certain intersyngen transfers was much lower than in intra-syngen 
transfers using the same mitochondrial preparation. 
Two classes of lowered transmission of erythromycin 
resistance wereroted. The first class, illustrated by reciprocal 
transfers between syngens 1 and 5, was shown to be due to a 
modification of the mitochondria by the nucleus of syngen 1 such 
that the organelles became altered in their ability to transmit 
erythromycin resistance to syngen 5. The second class, illustrated 
by transfers between syngens 5 and 7, was shown to be caused by the 
different syngenic origins of the mitochondrial genomes used. 
"Hybrid" cells containing mitochondria derived from one 
syngen by microinjection into the cytoplasm of another were used to 
show that the mitochondrial enzyme fumerase is coded for by the 
nuclear genome. 
8. 	An account of the possible approaches for characterizing 
specific proteins determined by the mitochondria has been given. The 
"hybrid" cells obtained in this work were considered important as they 
offer a unique tool for the identification of proteins coded for by 
the mitochondrial DNA. 
. 
GENERAL INTRODUCTION 
One of the characteristic features of eukaryotic cells is that 
they all contain mitochondria, the membrane bound organelles in which 
most cellular respiration is localised. The existence of various types 
of cytoplasmic inheritance had been accepted for many years but the 
demonstration by Naas, Naas and Afzeliva (1965) that mitochondria from 
many organisms contained small amounts of DNA gave a new impetus to the 
study of the biochemical genetics of mitochondria. 
It is now certain that the information encoded on the mitochondrial 
DNA is an essential part of the total inheritance of the eukaryotic cell. 
However, the exact nature of this information is less certain. 
In recent years, the greatest advances in our knowledge of the 
genetic system of mitochondria have come through two typescf approach. 
Biochemical examination of the properties of mitochondrial 
nucleic acids, particularly in the laboratories of Borst and Attardi, 
has set limits on the extent and nature of the information coded by 
mitochondrial DNA. 
Studies of recombination between antibiotic resistant markers 
in yeast, initiated by Linnane and his co-workers (Linnane et al, 1968a and b) 
and continued in the laboratories of Wilkie and Slonimaki, have provided 
much information about the nature of mitochondrial genes in yeast. 
Mjtochondrjal nucleic acids have been recently reviewed in 
detail by Borst (1972) and so only a brief summary will be presented here. 
Mitochondrial DNAs appear to be usually circular, and often super coiled 
molecules of defined length. There does not appear to be any relationship 
between the (GC) content of mitochondrial and their respective nuclear DNAs. 
2. 
The information content of mitochondrial DPIAs has been studied 
by quantitative renaturation experiments. Most mitochondrial DNAs studied 
follow ideal second order renaturation kinetics and so large scale hetero-
geneity is ruled out. !Xperimenta with several organisms involving 
hybridization of labelled ribosomal RNA to mitochondrial DNA has shown that 
each DNA molecule probably contains only one copy of each of the mitochon-
drial ribosomal RNAs. Similar experiments using transfer RNAs charged 
with specific amino acids have shown that mitochondrial DNAs code for 
between four and eleven transfer RNAs. It therefore seems that either 
some tR.NAe must be imported into the mitochondria or that proteins 
synthesised on mitochondrial ribosomes aunt have an unusual amino acid 
composition. 
Our knowledge of the proteins coded for by the mitochondrial 
DNA is still incomplete because definitive identification of these products 
requires the correlation of changes in mitochondrial proteins with changes 
in mitochondrial DNAs, something that has proved difficult until the 
present time. 
The following four approaches have been used generally in 
attempts to investigate this problem (from Borst, 1972). 
Pulse labeling with amino acids in the presence of specific 
inhibitors of mitochondrial or nucieo-cell-sap transcription or 
translation. 
Identification of the products of protein synthesis by 
Isolated sitochondrja. 
3. 
Identification of mitochondrial proteins that are not 
specified by mitochondrial genes because they can still be synthesized 
in the absence of functional mitochondrial DNA. 
Identification of the altered gene product in mutants that 
show cytoplasmic inheritance. 
Because of the interdependance of nucleo-cytoplasmic and 
mitochondrial contributions to mitochondrial biogenesis and the 
uncertainty about possible import or export of messenger RNA, results 
obtained from the first three methods should be viewed with some 
reserve, 
However, it does seem clear that, whatever the origin of the 
information, the products of mitochondrial protein synthesis are mainly 
hydrophobic proteins located in the inner membranes of the mitochondria, 
some of which may be closely associated with respiratory enzymes. 
In conclusion, while there is much circumstantial evidence to 
show that mitochondria DNA does code for proteins having important functions 
in mitochondrial biogenesis, many specific questions remain unanswered. 
Recent studies on the genetics of mitochondria, particularly in 
yeast, have demonstrated that mitochondria are capable of complex genetic 
reorganisation. Thomas and Wilkie (1968) were able to demonstrate 
independent assortment of the mitochondrial genes coding for chlor-
amphenicol and erythromycin resistance. By the analysis of large numbers 
of multifactorial crosses Slonimski and his group (Coen et al., 1969; 
Bolotin et al., 1970) have been able to analyse in detail the nature of 
sexuality in yeast mitochondria. In heterosexual crosses a polarity 
of transmission of markers is exhibited while in homosexual crosses 
 
no such polarity of transmission is observed. However, yeast remains 
the only organism in which it has been possible to demonstrate 
recombination of mitochondrial genes. 
Paramecium aurelia has several unique advantages for the 
study of mitochondrial genetics (Beale, 1954 and 1969). 
The genetic properties of this organism make it suitable for the 
analysis of cytoplasmic mutants and also for the study of nuclear genes 
found to affect thesemutantS. 
Paramecium contains large numbers of mitochondria and biochemical 
preparations of these are easily obtained. 
The large size of the cells has allowed firstly, the development 
of the technique of microinjection, and secondly, the study of quantitative 
mitochondrial genetics often not possible in many other micro-organisms. 
In general, the work presented in this study is concerned with 
the development of the technique of microinjection which was subsequently 
used to locate cytoplasmic erythromycin resistance in the mitochondria 
of P.aurelia. The technique of microinjection has also allowed the 
transfer of mitochondria from one syngen to others. During the course 
of this work several interesting interactions between the nucleo-cytoplasmic 
system and the mitochondrial erythromycin resistance were observed. 
5. 
MATERIALS AND METHODS 
Section I 	: 	General Methods 
Biochemical Reagents 
Inorganic chemicals, sucrose, and rafinose were obtained from 
British Drug Houses Limited and Hsons Limited. Biochemical reagents 
and enzymes were obtained from Sigma Chemical Company Limited, London. 
The erythromycin used was a gift from Dr. P. Slonimski. The radioactive 
14 C DNA prepared from E.coli was a gift from Dr. J. Bishop and the 
radioactive 14C RNA prepared from Xenopus laevis was a gift from 
Dr. Mary Lou Pardue. 
Strains 
(a) 	Several wild type erythromycin sensitive strains of Paramecium 
aurelia were used in this study. These were as follows: 
	
168 ES 	Syngen 1 	designated 	1(168)ES 
513 ES 	It if 	 1(513)BS 
92 ES 	Syngen 3 	 if 3BS 
51 ES 	Syngen 4 	 to 	4ES 
87 ES 	Syngen 5 	 5BS 
227 ES 	Syngen 7 	 7ES 
214 ES 	Syngen 8 	 8ES 
328 ES 	Syngen 14 	 14ES 




Spontaneously occurring erythromycin resistant strains have 
been isolated from some of the wild type stocks listed above. Two of 
these 1ÔSER1 and 87ER1 were used in this study. Both of these strains 
are resistant to 250 .Lg/ml erythromycin and are designated l(16)E1 
and 5 ER respectively. The genetic analysis of these has been described 
(Beale, 1969; Beale et al., 1972). 
"1ybrid" strains 
Erythromycin resistant "hybrid" strains are stocks derived 
from a cell injected with mitochondria from another syngen. Several 
classes of these were produced during this study. These were as 
follows: 
Symbolic name mitochondria Recipient 
5ERm1. 1 E 5BS 
7ERm1. 1 72S 
7ERm5. 5R 7B5 
lERml.5. 5ERm1. 1ES 
7ERm1.5. 5ERm1. 7135 
5 ER m 1.5.1. 1 BR m 1.5. 5ES 
Nomenclature of Strains 
Each strain has a stock number derived from the isolation 
number assigned when the original clone was isolated from a natural 
population. This is followed by either the letters ER signifying 
resistance to erythromycin, or ES signifying natural sensitivity to 
100 pg/ml erythromycin. A subscript number following this is the 
7. 
isolation number of the mutant strain. '1Hybrld" stock names have the 
subscript 'in' followed by the number of the syngens into which the 
erythromycin resistance had previously been injected. For example, 
7 ER 	contains mitochondria originally isolated from syngen 1, 
injected with syngen 5, reisolated and injected with syngen 7. 
3. 	Culture Media 
Concentrated Grass Infusion 
1200 grams of dried grass was boiled in 10 litres of distilled 
water for ten minutes, stirring continuously. After cooling, the suspension 
was filtered once through four layers of, butter muslin. The filtrate was 
passed through an U.S.E. continuous flow centrifuge head spinning at 
15,000 r.p.m., at a flow rate of 200 ml. per minute. The effluent was 
collected in Thomson bottles and autoclaved for 20 minutes at 20 pounds 
per square inch. This solution was used for making up growth media as 
follows: 
Mass Culture Medium 
500 mis. of the concentrated grass infusion was diluted with 
350 ml. of M15  Na2H PO4 and made up to 10 litres with distilled water. 
One litre aliquots were placed in Thomson bottles and dutoclaved ready 
for use. 
Slide medium 
50 mis. of concentrated grass infusion were diluted with 70 ml. 
of M'5 Na211 PO4 and made up to two litres with distilled water. 400 ml. 
aliquots were placed in 500 ml. flasks and autoclaved ready for use. All 
culture of Paramecium was carried out using bacterized medium. The medium 
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was bacterized by inoculation with Kiebsiella aerogenes cultured on 
agar slants and incubated for 12 to 18 hours at 310C. The bacterized 
medium was adjusted to pH 6.8 to 7.0 with 2 Normal Sodium Hydroxide 
immediately before use. 
4. 	Culture of Cells 
A detailed description of methods Used for the culture of 
paramecia is given by Sonneborn (1950,1971). A brief outline is given 
here as some of the methods used differ from those previously described. 
1ide and Tube Cultures 
election for erythromycin resistance following microthjection 
and routine maintenance of stocks was carried out using bacterized slide 
medium. Erythromycin was made up in a stock solution of 0.5 grams in 
20 mis. of analar ethanol. This stock solution was diluted one hundred 
fold with bacterid slide medium to give a final c'ncent ration of 
250 pg/mi. in the selective medium. Sensitive cells which had been 
microinjected with cell extracts were washed once and placed in elective 
medium at 240 	 0 C after being left overnight at 18 C to recover from the 
"operation" 
Strains which were to be wed for microinjection were grown 
in tubes at 180C and were fed weekly in order to maintain them in the 
best physiological condition. 
Mass Cultures 
Cells in 20 ml of slide medium were inoculated into 500 mis. 
of freshly bacterized slide medium and incubated at 31°C until the 
9. 
culture cleared as the paramecia ingested the bacteria. The cells 
were inoculated into 1 litre of bacterized mass culture medium and 
this medium allowed to clear. This one litre of cells then served to 
subinoculate up to 8 litres of bacterized mass culture media. The cells 
were grown up at 24°C. When the paramecia had cleared the bacteria, 
the culture was ready for harvesting. 
Harvesting of Paramecia. 
Mass cultures were first filtered through a layer of absorbent 
cotton wool to remove debris from the culture. The filtrate was passed 
through an M.S.E. continuous flow centrifuge head spinning at 3,000 r.p.m. 
at a flow rate of 800 ml. per minute. The cells were resuspended in 
approximately 300 ml. of Dryl's medium (Dryl, 1965) and recentrifuged 
in an M.S.E. oil testing centrifuge. The pelleted cells were resuspended, 
pooled and washed twice with Dryl's medium-to remove as many bacteria as 
possible. 
Preparation of Cell Extracts 
The cell extracts prepared for rnicroinjection were of four 
types; the first three were prepared by differential centrifugation 
and the last by a sucrose one step gradient. 
(a) 500 g. Supernatant 
Between 2 and 4 mis. of packed cells were diluted with 10 
volumes of ref inose homogenization buffer containing 0.215 M raf inose, 
2.5 mg/nil bovine serum albumin and 0.01 M potassium phosphate, pH 6.2 
(Preer and Preer, 1959). The resulting suspension was homogenized twice 
in a cream homogenizer and spun for five minutes at 500 g. in an M.S.B. 
10. 
high speed 18 centrifuge at 40C. The resulting supernatant was used 
either for microinjection or for preparing other cell fractions. 
5000g. pellet 
This type of preparation will be referred to as a mitochondrial 
preparation as it contains at least 80% mitochondrial and is the cell 
fractioo most freuenc Iv used in this work. The 500 g. supernatant was 
spun at 5,000 g. for 2 minutes- at speed and then the supernatant was 
discarded. On some occasions this supernatant was saved for microinjection 
in control experiments. 
The walls of the tube were wiped with absorbent tissue to remove 
lipids adhering to them. The top section of the pellet, containing a 
higher proportion of cilia and bacteria (Preer and Preer, 1959) was 
washed off with homogenization buffer. The centre section of the 5000 g. 
pellet was carefully resuspended in 0.1 ml. of homogenization buffer 
and placed in a serum tube in ice. The lower quarter of the pellet, 
containing a higher proportion of trichocysts was discarded. 
Preparation from a D O/H20 Interface 
This procedure was devised to obtain preparations of mito-
chondria purer than previous methods, without the excessively long times 
required (3 hours) by linear sucrose gradient techniques. The 500 g. 
supernatant was placed on a 20 ml. 50% aqueous sucrose cushion, itself,  
supported on a 4 ml. 50% deuterium oxide-sucrose cushion in a 40 ml. tube. 
The D 
2  0 sucrose cushion was inserted into the bottom of the tube just 
before use to prevent mixing of the D 2 0 and H 
2  0 layers. This two step 
11. 
gradient was then centrifuged at 10,000 g. for 15 minutes in a 3 x 40 
swing-out rotor and allowed to come to rest without braking. The base 
of the tube was pierced and the H20/D20 sucrose interfaces, containing 
a large proportion of the mitochondria, collected. This preparation 
was then diluted once with raf inose homogenization buffer so that the 
cells injected were not killed by the high sucrose concentrations. 
7. 	Treatment of Mitochondrial Preparations with DNAse, RNAse 
and Detergent. 
(a) DNAse and RNAse Treatment 
A initochondrial preparation was made as previously described 
except that the 500 g. supernatant was divided into two equivalent parts 
so as to produce two equivalent 5,000 g. pellets. One of these pellets 
was resuspended in a solution containing 0.215 M re-f inose, 1.5 mg./ml. 
bovine serum albumin, 0.01 M potassium phosphate pH 6.2 and 1 mg./ml. 
of nuclease. The other pellet was resuspended in a similar buffer 
without nuclease. 
Two nucleases were used in this study: 
DNAse II purified from hog spleen. This was used in preference 
to DNAse I as it has little or no magnesium requirement. Magnesium in 
concentrations as low as 10 molar causes extensive clumping of 
mitochondria and consequently renders the preparation impossible to 
inject. 
Ribonuclease A purified from bovine pancreas and crystallized 
five time. This preparation is described as protease free. 
(b) Detergent Treatment of Mitochondrial Preparations 
The equivalent 5600 g. pellets were prepared as described 
previously; one of these was resuspended in 0.1 ml. raf inose homogenization 
buffer containing 1.5% Triton x 100 and the other was resuspended in 0.1 ml. 
of homogenization buffer without detergent. 
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Treated and untreated preparations were injected alternately 
with sensitive paramecia so as to eliminate errors due to differences 
in time between homogenization of the cells and injection into a cell. 
(c) A yf9r DNAse and RNAse activities in the Homogenisation Buffer 
A solution was made up containing 1 mg/ml specific nuclease, 
1.5 tg./ml. bovine serum albumin, 0.215 M rafinose and 0.001 m. potassium 
phosphate and preincubated at 0°C in an ice bath. The experiment was 
initiated by the addition of 0.5 ml. of a solution containing DNA or 
14 C the nuclease solution. This resulted in a reaction mixture 
containing initially at least 500 T.C.A. precipitable counts per minute. 
At various times 0,1 nil. aliquots were diluted with 2 ml. of 
10% T.C.A., 0.1 M NaCl at 0°C. This was then filtered onto fibre glass 
disks and the T.C.A. precipitable radioactivity estimated by counting 
for ten minutes in a Nuclear Chicago scintillation counter. 
8. 	Electron Microscopy 
(a) Mitochondrial Pellets. 
Mitochondrial pellets prepared as described in section 6b were 
resuspended in an Orninum fixative and spun at 15,000 g. for 30 minutes 
at 0°C. The fixative was prepared to the following formula (Jurand 
and Selman, 1968). 
Solution A. Sodium Veronal 	14.714 gm. 
Sodium Acetate 	9.714 gm. 
Distilled water 	to 	500 nil. 
Solution A is made up and kept at room temperature. Solution 
B is prepared freshly for each fixation. 
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was complete the cells were transferred to 50/50 araldite/ethano]. 
In a solid watch glass. After 30 minutes the cells were transferred to 
pure araldite and stirred on a rotary shaker for 2 hours. They were 
then transferred individually to the top of a gelatin capsule 
containing partially prepolymerised araldite and polymerised at 600C 
for 24 hours. After careful trimming, the single cells were sectioned on 
a Porter-Blum ultra mictotome and mounted on colloidon carbon-coated 
grids. 
Staining was carried out by floatation on a 1% solution of 
potassium permanganete containing 2,5% uranyl acetate for 20 minutes. 
Excess stain was removed by floating the grids on distilled water, 
then on 0.25% citric acid for 30 seconds, followed by three changes 
of distilled water. The sections were then examined in an A.B.1. ÔB 
electron microscope at 60 kilovolts. 
9. 	Control Experiments for Inter-syngen Transfers 
Towards the end of each experiment, at least 10 sensitive 
cells of the same syngen as those used for the mitochondrial preparation 
were injected. The subsequent development of erythromycin resistance by 
these cells served to confirm that the mitochonctrjal preparation was 
still 'viable'. 
In addition, at least 24 uninjected cells of each syngen were 
isolated into the medium used to select for erythromycin resistance to 
check that growth in this medium was specifically related to the 
acquisition of erythromycin resistance. 
15. 
io 	Starch (e1 Electrophoresis 
The method used has been described in detail by Tait (1969) 
and is essentially similar to that described by Smithies (1955) 
and Smith (1968). 
250 ml. of cells is harvested on an oil testing centrifuge 
and the pelleted cells homogenized in a sucrose phosphate buffer. 
Mitochondria were prepared by differential centrifugation and 
homoerdzed in Triton X 100. A 75,000 g. supernatant was absorbed 
onto small pieces of chromatography paper wlich was then inserted 
into slits in a 9-11% starch gel (Connaught Research Laboratories). 
Electrophoresis was carried out at constant voltage at 00C for 3.5 
hours. The gels were specifically stained for fumerase activity 
using the dye MTT tetrazolium and then washed overnight in tap 
water. 
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Figure 1: The apparatus used for microinjection. This shows 
the injection system (I), and the immobilization 
system (b). 
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section II 	: The Technique. of Microinjection 
The aim of this technique is to insert a quantity of fluid 
into the cytoplasm of a single Paramecium cell. 
1. 	Apparatus 
The apparatus described here is similar to that used by 
Koizumi and Preer (1966). However the system has been considerably 
improved during the course of this work, so that it is now possible 
to inject large numbers of cells (up to 80) in a relatively short 
time 0 hours), 
The components of the system are as follows (see Figure 1). 
Microsooe 
A Carl Ziess Mark III stereo-zoom microscope fitted with a 
x 2 objective and x 25 eyepieces, one of which carries a graticule, 
is used to observe the injection. A maximum magnification of x 200 
allows accurate placing of the injection needle in the cell. A 
Gillett and Sibert stage with concentric controls is dampdd to the 
illumination base of the microscope. This stage holds a perspex moist 
chamber of dimensions 25 mm. x 20 mm. x 0.5 mm. covered by a 32 nun. x 
44 mm. coverslip (chance No.2 grade). The paramecium cells to be 
injected are placed in small hanging drops around a central drop of 
mitochondrial preparation on the underside of this coverslip. 
The Injection System 
An Agla microinjection unit (Wellcome) attached to a solid 
base, containing a Hamilton 50 microlitre syringe is connected by 
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1 mm. internal diameter polyethylene tubing (L.K.B.) to a pyrex glass 
microinjection needle with a tip of internal-diameter 3 microns. The 
whole system is fitled with oil and should be completely air free so as 
to provide precise control of the pressure in the injection needle. The 
injection needle is held and controlled by a de Fonbrune pneumatic micro-
manipulator. 
(C) The Cell Immobilization System 
To immobilise the cell just prior to injection, the liquid 
in which the cell is swimming is partially removed. The cell is then 
held stationary by surface tension and friction against the coverslip. 
The liquid is removed by a second glass needle with a very large tip 
diameter (200 microns) connected to a second Agla micrometer syringe 
unit containing a 2 ml. glass syringe. This system is filled with a 
Dryl's solution (Dryl, 1965) containing 2 mg./ml. bovine albumin. The 
immobilization needle is positioned by a micromanipulator (Research 
Instruments) on which the vertical and horizontal motions are separated. 
(d) Location of the Apparatus 
The whole microinjection apparatus is placed on a 1 metre x 
0.66 metre concrete paving slab supported by 2 inch rubber bungs placed 
on a firm metal framework. This is enclosed in a small room having 
space for the operator and an additional service binocular microscope 
on a bench at right angles to the injection equipment. This room is 
situated in an 18°C constant temperature room in order to prevent the 
rupture of cells which may occur at higher temperatures. 
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2. 	Preparation and adjustment of the apparatu 
Making microinjection needles 
Needles for microinjection were made from pyrex tubing using 
an automatic electrode puller. The last 5 mm. of each needle wa bent 
to an angle of between 12 to l: degrees from its main axis with a 
microflanie. The tips of the injection needles were broken off against 
a solid surface under a microcope to give an internal tip diameter of 
3.0 + 0.1 microns. 
Changing the microinjection needle 
The Luer-Lock fitting is removed from the 50 microlitre 
syringe and filled with oil. The new needle is inserted into the tube 
and this is then reclamped in the micromanipulator. The needle is then 
repositioned in the field of view and filled with oil by pressing the 
Luer fitting firmly onto the syringe. This action forces the oil up 
the injection needle so expelling the air. 
Filling the Immobilisation system 
When not in use the immobilisation system is kept full of ethanol 
to ensure sterility. The ethanol is rinsed out with 2changof distilled 
water and the system filled with Dryl's solution containing 2 mg./ml. B.S.A. 
Treatment of Cells. 
Prior to microinjection the cells to be injected were placed in 
Dryl's/B..A. solution in a depression slide. This is to protect the 
cells against excessive tension produced during immobilisation. After 
microinjection the surviving cells are returned to fresh bacteriZed 
medium and left overnight at 180C. 
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3. 	The method of Microinjection. 
Individual freely swimming paramecico are placed in small 
hanging drops on a coverlip (Chance, 22 mm. x 40 mm., No.2). In the 
centre of the coverslip is placed a small drop of the cell extract to 
be injected. The coverslip is then inverted and placed on the moist 
chamber. 
A standard quantity of the cell extract, usually about 6 
nan.)litres, is drawn up into the injection needle. This is achieved 
by moving the oil/extract meni-cus up the needle a given distance as 
measured by the eye piece micrometers. 
The free liquid supporting a cell is removed with the 
immobili:ti.on system, -n that the cell I: heLd tationary 	aint the 
coverslj 	 1 
(ci) 	The zoom lens is changed to give x 200 magnification and the 
injection needle is inserted into the cell. The best position for this 
is between the posterior contractile vacuole and the macronucleus, but 
other locations are possible. When the needle is seen to have penetrated 
the cell, the cell extract is gently expelled from the needle. Frequently 
the fluid from the needle can be seen to displace the cytoplasm in the 
cell. 
needle 
The injection/is rapidly removed and the cell releaed by 
flooding the slide with the immobilisation system. 
If the cells or cell extract leave particulate matter on the 
outside or inside of the injection needle this is removed by rinsing the 
needle with a solution of 2% TritonX 100 and then rinsing with 
distilled water. 
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4. 	Factors affecting the success of microinjection 
Composition of the fluid in which the injection is carried out. 
Initially, the variation in the physiological state of the cells 
and the variable surface tension of the bacterised grass medium in which 
the cells were growing, produced very variable injection success. 	For 
this reason a more defined medium with reduced surface tension was 
developed. The best medium was found to be Dryl's B.S.A. (see Section 
2c). The use of this solution considerably simplified the technique 
of microinjection such that whereas initially it was only possible 
to inject approximately 5 cells per hour, it is now possible to 
inject 30-40 cells per hour. 
The angle of the microinjection needle 
The precise angle 	the injection needle makes with the 
coverslip was found to be very important for the successful injection 
of cells. If this angle is too low the needle will not penetrate 
the cell. If the angle is too high, the needle is pushed through the 
cell and the fluid to be injected is expelled on the other side of the 
cell. The optimum angle has been found to be between 12 and 18°  from 
the horizontal, but this varies with the exact nature of the needle 
tip and the physiological condition of the cells being injected. 
The size and shape of the microinjection needle. 
The larger the needle tip diameter the more difficult it is 
to insert the needle into the cell. If the needle is too small it will 
not allow the free passage of the larger cytoplasmic components such as 
mitochondria and trychocysts. The optimum size of needle for this study 
was found to be one having an internal diameter of 3 microns. 
21. 
(d) Physiological condition of the cells used for microinjection 
Cells used for microinjection should be in late log phase or 
early stationary phase. At this stage of growth the cells are at their 
largest and have a greater ability to recover from injection than cells 
taken from cultures in early log phase or late stationary phase. 
5. 	Quantitative Estimates 
(a) Estimation of mitochondrjaj, concentration 
An estimate of the numbers of mitochondria per unit volume in 
a preparation of mitochondria was obtained by counting a sample of 
the preparation which had been dibuted tenfold in a special 11400 mm 2 x 
0.01 mm grid square counting chamber (Hawkesly). 
For each preparation the number of mitochondria-like objects in 10 
groups of ten squares on the grid were counted. This technique was 
found to give an estimate accurate to + 30% (+ 2 standard deviations) 
of the concentration of mitochondria-like objects counted. 
(b) Estimation of the volume inserted by injection 
Paraffin oil was drawn into the injection needle a given distance, 
measured by the eyepiece micrometer. This was normally 20 micrometer 
units or 226 microns length. This oil was gently expelled into a 
solution containing detergent, and the diameter of the spherical 
drop so formed measured with the micrometer. Oil Occupying a length 
Of 226 microns in the needle produced a sphere of diameter 22.6 microns. 
The volume of this sphere was found to be 6 9000 cubic microns or 6 
nanolitres. No siginficant variation was found between nectiles with 
the same internal tip diameter. 
22. 
(c) Calculation of the dilution required to inject a known mean number 
of mitochondria per cell. 
Let:- 	1) a be the initial undiluted concentration of mitochondria- 
like objects 
ii) A be the number of mitochondria like objects seen per square 
A x 102 Then 	
a = 2.5 	10 	per cubic micron 
as the volume of a counting grid square is 2.5 x 10 . 
The volume of the injection, v = 6 x 10 33  
Therefore, the number of mitochondria injected if the 
solution is not diluted is a.v. = 24k, 
The number of mitochondria injected per cell if the original 
preparation is diluted d-fold = a'r  
If we wish to inject y mitochondria-like objects per injection, 
a.v then y =-i-- 
Typical values are 	A = 11.01 
y = 5 (or 1) 
Then, 	 d = 53 
The original mitochondrial preparation is then diluted 1:53 
so as to make a solution such that an average of five mitochondria are 
injected into each cell. 
CHAPTER I 
The Nature and Location of Cytplasmically Inherited Erythromycin Resistance 
in Paramecium aurelia. 
Introduction 
Non-Mendelian mutants of Saccxomyces cerevisiae resistant to 
the antibacterial antibiotic erythromycin have been isolated by several 
workers (Clark-Walker and Linnane, 1966; Lamb, Clark-Walker and Linnane, 
1967; Coen et al., 1970). Experiments involving reciprocal crosses 
between antibiotic resistant markers and the p factor res,onsible for 
petite forms in yeast have shown that erythromycin resistance is caused 
by a heritable change in mitochondrial DNA (Thomas and Wilkie, 1968; 
Linnane et al., 1968a). 
In Paramecium, Beale (1969) was able to obtain mutant cells 
having the ability to grow normally in the presence of 250 .tg/ml erythro-
mycin-sensitive, wild-type cells are unable to grow for more than a few 
fissions in concentrations of erythromycin as low as 70 jLg/ml. This 
erythromycin pesistance was shown to be due to a cytoplasmic factor. 
Adoutte and Beisson (1971 and 1972) and Beale et al., 1972 isolated many 
mutants of P.aurelia, resistant to both erythromycin and chioramphenicol, 
all of which seem to be determined by cytoplasmic factors. 
The aim of this work was to locate the site of cytoplasmically 
inherited erythromycin resistance in Paramecium aurelia. Using the 
technique of niicroinjection, evidence has been obtained that resistance 
to erythromycin is located in the mitochondria, probably on the 
mitochondrial DNA. Preliminary results are discussed which suggest that 
only one mitochondria is required to transfer erythromycin resistance 
into sensitive cells. 
23. 
(Reprinted fron? Nature, Vol. 235, No. 5338, pp. 396-397, 
February 18, 1972) 
Mitochondrial Genetics 
in Paramecium 
RESISTANCE to erythromycin and chloramphenicol in yeast has 
been shown to be controlled by non-Mendelian genetic factors 
in mitochondrial DNA". Because paramecium has particular 
advantages for the study of cytoplasmic genetics', we have 
made some genetic and biochemical studies on drug-resistant 
variants of this ciliate, working with syngens 1 and 4 of P. 
aurelia. 
When paramecia are placed in bacterized lettuce medium 
(pH 6.8-7.0) containing 0.25 mg ml.' erythromycin, growth 
stops after one to three fissions, but thereafter the ciliates 
remain alive for a considerable time. Between two and four 
weeks afterwards, erythromycin-resistant mutants appear 4 '5, 
at a frequency of about 1 per 1,000 paramecia initially present. 
Paramecia resistant to chloramphenicol (0.25 mg ml.-I) have 
also been obtained, but only after treatment with a mutagenic 
chemical (nitrosoguanidine). The variants have been shown 
to be stable for between one and two years when grown in 
media lacking antibiotics. 
Genetic tests have shown, both in syngens 1 and 4, that 
resistance to both drugs is inherited through the cytoplasm at 
conjugation. When there is no cytoplasmic mixing at con-
jugation between sensitive and resistant paramecia (the normal 
situation), one of the ex-conjugant clones consists of resistant 
animals and the other sensitive. When there is cytoplasmic 
mixing, which occurs commonly in stock 51 (syngen 4), but 
rarely in other stocks unless induced by special treatments6, 
both ex-conjugants produce drug-resistant animals. 	The 
cytoplasmic basis of inheritance of erythromycin resistance was 
confirmed by a programme of repeated back-crossing to 
sensitive animals. No effect of nuclear genes on drug resistance 
has been shown, but the matter has not been intensively 
studied. 
Cytoplasmic mixing between erythromycin-resistant and 
chi oraniphenicol-resistant conjugants results in the production 
of paramecia capable of growing in either antibiotic, but not 
in medium containing both. Such "mixed" clones, after growth 
in one antibiotic for a few (ten to fifteen) fissions, lose their 
resistance to the other antibiotic. When grown in drug-free 
medium for a hundred or more fissions, however, "mixed" 
clones may retain their capacity to grow in the presence of either 
antibiotic, although lines containing animals resistant to 
erythromycin alone appear sporadically. Thus in one experi-
ment, six hybrid clones containing mixtures of cytoplasm from 
stocks 51-Er (EDIN) (erythromycin-resistant) and 51-C 
(EDIN) (chloraiiiphenicol-resistant) were grown in normal 
medium. Chloramphenicol resistance was lost after forty-seven 
fissions in one clone, after 106 fissions in three clones and after 
195 fissions in the sixth clone. Erythromycin resistance was not 
lost at all in this experiment. 
Similar experiments were done with clones containing mix-
tures of resistant and sensitive cytoplasm and the results 
indicated that there was a slight selective advantage of "wild 
type" or sensitive (51EsCs)  cytoplasm over 51-El' and of 
51-Er over 51-C, but these are probably strain or mutant-
specific characteristics, judging by the different results obtained 
by Adoutte and Beisson7. 
Attempts to obtain "recombination" between 51-Er (EDIN) 
and 51-C (EDIN) cytoplasmic components by selection of 
doubly resistant animals have so far failed, although such 
doubly resistant types have been obtained by mutation. 
In an attempt to identify the particular cytoplasmic factor 
associated with the transfer of antibiotic resistance, various cell 
fractions were prepared from erythromycin-resistant paramecia 
(168-Er (EDIN) and injected into sensitive paramecia (168-E5  
(EDIN)) using a micro-injection technique'. 
Two methods of preparing cell fractions for micro-injection 
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Fig. 1 Electron micrograph of an osmium fixed mitochondrial 
preparation, pelleted and embedded in 'Araldite'. M, Mito-
chondria; b, bacteria: s, fragments of surface membrane; 
c, cilia; t, trichocysts. 
into sensitive cells were used. (i) Packed cells were resuspended 
in four volumes of a sucrose buffer (0.3 M sucrose, 100 mg ml.-' 
bovine serum albumin, 0.001 M potassium phosphate, pH 
= 7.0) at 4° C and were twice homogenized in a cream homo-
genizer. After centrifugation at 1,500g for 7 mm, the super-
natant, which would be expected to contain most cell com-
ponents except macronuclei and large pieces of pellicle, was 
used for micro-injection. Of a total of thirty-four surviving 
cells injected with this type of preparation, twenty-three 
developed the ability to grow in erythromycin after a delay of 
9-15 days at 24° C. None of the seventy-four uninjected 
controls became resistant. (ii) Mitochondria were prepared by 
differential centrifugation in raffinose buffer'. The centre 
section of the "mitochondrial" pellet was resuspended in the 
smallest possible volume (about 0.5 ml.) of the raffinose homo-
genization buffer and injected into paramecia as soon as 
possible. 
An estimate of the composition of this preparation was 
obtained by examination of an osmium-fixed pellet under the 
electron microscope (Fig. 1). The following percentages of 
various particulate components were found: mitochondria, 
80%; bacteria, 10%; fragments of surface membrane, 4%; 
cilia, 11NO;  trichocysts, 41%; other, 1%. These percentages 
represent the numbers of each component in relation to the 
total number of particles counted. 
Of sixty-four animals injected with this preparation, fifty-four 
became resistant after 4-15 days while none of the 132 uninjected 
controls developed resistance. Five cells injected with the post-
mitochondrial supernatant and eleven cells injected with 
preparations from sensitive cells did not become resistant. The 
spontaneous mutation rate is of the order one in .10'  cells 
(one in 101  mitochondria), so these results are felt to be highly 
significant. It is also important to point out that positive 
results were only obtained following the use of an injection 
needle with an internal diameter of not less than 3.0 urn and 
that this corresponds well with the size of the mitochondria of 
paramecium (2-4 tm diameter). Although the injected material 
did not consist exclusively of mitochondria, our results are 
entirely consistent with the view that transfer of resistance from 
one cell to another was in fact mediated by these organdies. 
Our further work has concerned the site and biochemical 
nature of the alterations produced in drug-resistant paramecia. 
Erythromycin and chloramphenicol are both known to inhibit 
protein synthesis on bacterial ribosomes, and alterations in the 






Fig. 2 a, Comparison of densitometer traces of stained acryl-
amide gels of separated "crude" mitochondrial ribosornal 
proteins from strains 513-Es (EDIN) ( --- )  and 513-E 
(EDIN) (—). The proteins are numbered 1-16 from the 
origin, marked 0. b, Photograph of the acrylamide gels scanned 
in a. The difference between the two strains in band 1 is 
indicated by the arrow. 
4 
ribosomal proteins have been shown to occur in erythromycin-
resistant strains10, so we have investigated the possibility of 
similar alterations in the mitochondrial ribosomal proteins of 
drug-resistant paramecia. 
Twice-washed mitochondria were prepared by differential 
centrifugation' and then lysed by homogenization in 20//0 
'Triton X-100 TMK' (50 mM Tris-HCI, pH 7.5, 10 M MgCl2, 
10 mM KCI), using a 'Teflon' glass homogenizer. The mito-
chondrial ribosomes were separated by differential centrifuga-
tion of this lysate" and the proteins extracted from the crude 
ribosomal pellet by treatment with 4 M LiCI-8 M urea at 
40  C for 12 h, the RNA being removed by centrifugation after 
this treatment 12. The ribosomal proteins from resistant and 
sensitive strains were then compared by acrylamide electro-
phoresis at pH 4512,13 Electrophoresis was carried out for 
4 h at 4 mA gel' at 4° C. The gels were stained with 1% 
naphthalene black for I h, destained electrolytically in 7% 
acetic acid and scanned using a Joyce-Loebi ultraviolet scanner. 
The electrophoretic pattern of these proteins shows some 
sixteen bands (Fig. 2) and differences have been observed 
between sensitive and drug resistant strains. For example, 
comparison of 513-El (EDIN) (syngen 1, sensitive) with 
513-E (EDIN) (syngen 1, spontaneously erythromycin-
resistant) shows a quantitative alteration in a single protein 
band (No. I) (Fig. 2). The difference observed was found 
consistently in different electrophoretic runs and using indepen-
dent preparations of the crude ribosomal proteins from the two 
strains. The ratio of the area under peaks 3 and 4 to the area 
under peak 1 has been calculated for the two strains and the 
difference between this ratio for 513Es  (EDIN) and 513-E 
(EDIN) was shown to be significant. While it is realized that 
the preparation of mitochondrial ribosomal proteins is crude, 
these results are consistent with the view that the change from 
sensitivity to erythromycin resistance involves the alteration 
of one or more proteins associated with the mitochondrial 
ribosome. 
The precise nature of this difference has not been ascertained 
but various possible explanations are now being investigated. 
Attempts are also being made to establish unequivocally the 
mitochondrial ribosomal origin of this protein. 
Our results show that erythromycin resistance and chlor-
amphenicol resistance in F. aurelia are due to cytoplasmic 
genetic factors located in the mitochondria (confirming the 
findings with yeast). These mitochondrial "genes" modify 
certain proteins associated with the mitochondrial ribosomes. 
The special features of the paramecium material, such as the 
very large size of the "cells", permitting transfer of mitochon-
dria by micro-injection, the fact that the reaction of individual 
5 
cells to the drugs can be studied, and the large size and number 
of mitochondria per cell (as compared with yeast) will make 
possible the elucidation of new features of mitochondrial 
genetics. Further technical and other details of this work will 
be published elsewhere. 
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A New Method for Studying the Genetic Control 
of Specific Mitochondrial Proteins in Paramecium aurelia 
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Received March 16, 1972 
Swm?nary. Mitochondria from one syngen (or sub-species) of Paramecium aureiw have 
been introduced into a different syngen by preparing erythromycin-resistant mitochondria 
from syngen 1 and micro-injecting them into erythromycin-sensitive syngen 7 cells. The reci-
pient sensitive cells were then placed in erythroinyc'in to inhibit the replication of the sensitive 
mitochondria. Such selected clones contain a syngen 7 nucleus but a mitochondrial genome 
which is derived from syngen I erythromycin-resistant mitochondria. 
Using this niethod it has been shown that the mitochondrial enzyme fumarase is not coded 
by the mitochondrial genome, and bv implication, is coded by the nuclear genome. The use of 
this technique as a method for determining if specific mitochondrial proteins are controlled 
by nuclear or mitochondrial genes is discussed. 
lfltrO(lUCtiOII 
It is now well established that mitochondria contain DNA (Borst and Kroon, 
1969; Ashwell and Work, 1970; Borst, 1972), but many of the specific functions 
of this DNA remain to be determined. Hybridization studies with mitochondrial 
ribosomal RNA and transfer RNA have shown that mitochondrial DNA codes for 
these molecules (Borst and Aaij, 1969; Nass and Buck, 1970: Attardi et al.. 1970; 
Borst and Grivell, 1971; Aloni and Attarcli, 1971 a, b and c). In animal mito-
chondria the RNA-DNA hybridization plateaus indicate that 20-25% of the total 
genome codes for the mitochondrial ribosomal and transfer RNA (Borst, 1972). It 
seems likely that the remaining DNA sequences code for certain mitochondrial 
proteins and several experimental approaches are available for investigating which 
mitochondrial proteins are involved. These approaches can be summarised as 
follows (Borst, 1972): 
amino acid incorporation into mitochondrial proteins in the presence of 
inhibitors of mitochondrial or cytoplasmic protein synthesis, followed by 
identification of the labelled products; 
analysis of the proteins labelled when isolated mitochondria are incubated 
with labelled amino acids; 
identification of mitochondrial proteins synthesised in the absence of 
mitochondrial DNA in petite mutants with no rn-DNA: 
identification of altered proteins in drug resistant, cytoplasmically in-
herited mutants. 
Evidence supplied by these approaches is often difficult to interpret unambi-
guously (Nass, 1969: Ashwell and Work, 1970: Rabinowitz and Swift, 1970; 
Kroon and de Vries, 1970; Borst and Grivell, 1971: Mahler et al., 1971). In the 
case of approaches (i) and (ii) the synthesis of certain proteins may depend on 
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components from both nuclear and mitochondrial genomes, so that one may under- 
estimate the number of proteins coded for by the nucleus or mitochondria. Also, 
mitochondrial messenger RNA may be translated on cytoplasmic ribosomes or 
nuclear messenger RNA may be translated on mitochondrial ribosomes and this 
would confuse the interpretation of these results. Using petite cells, described in 
(iii), the mitoehondria are grossly altered and some of the proteins coded for by 
the nucleus may depend on a complete mitochondrial structure for incorporation 
and synthesis. The major disadvantage of approach (iv) is the limited number of 
drugs and resistant mutants which are available; this approach also requires that 
crosses can be made between resistant and sensitive cells. 
The approach described in this paper does not depend on the use of extensively 
altered mitochondria or drug inhibited systems. Cytoplasmically inherited cry-
thromycin-resistant mutants have been obtained in Paramecium (Beale, 1969; 
Adoutte and Beisson, 1970) and evidence has been obtained, showing that the 
mutation is mitochondrial (Beale et al., 1972). In the present study, the original 
sensitive mitochondrial population of a cell has been replaced by an erythromycin- 
resistant population of mitochondria, derived from a sub-species winch is sexually 
isolated from the recipient cell. This approach allows the study of clones which 
derive their mitochondrial genome from one syngen (or sub-species) and their 
nuclear genome from another. Intersyngenic variation of mitochondrial proteins 
allows the localisation of the genetic information for a variant protein to be made 
by micro-injection of mitochondria between sexually isolated sub-species. 
Fumarase has been shown to differ in electrophoretic mobility between syngens 
(Tait, 1970a) and in this paper, this difference is used to show that fumarase is 
controlled by the nuclear genome. 
Materials and Methods 
Stocks: stocks 168 (syngen 1), 227 (syngen 7) and the spontaneous erythromycin resistant 
mutant 168 E (Edin), derived from 168. of Paramecium aurelia were used. The mutant stock 
grows at normal rate in 250 sg/ml of erythromycin. 
Cultures: stocks were cultured on a grass infusion, buffered with phosphate, and bacterized 
with _4erobacter aeroqenes (Sonneborn, 1950) at 25 C. 
iTlitorhondria: 10 L. cultures of Paramecium were filtered through cotton wool and the 
cells pelleted by continuousflov centrifugation at a flow rate of 700m1/min at 500g. The packed 
cells were resuspended in Dryl's solution and pelleted by centrifugation at 1500 r.p.m. for 
4 mm. in an M.S.E. oil-testing centrifuge. The pelleted cells were disrupted in 10 volumes of 
buffered raffinuse (I'reer 1959) by homogenisation in a cream homnogeniser. Mitochondria were 
then prepared by differential centrifugation as previously described (Beale et at., 1972). 
itJscro-injection: The technique used was essentially that of Koisumi and Preer (1966) but 
with modifications to be described elsewhere (Knowles, in press). A thick suspension of mito-
chondria prepared from resistant syngen 1 cells was micro-injected into single sensitive syngen 
7 cells. The viability of the mitochondrial preparation was estimated by injecting it into sen-
sitive syngen 1 cells. This was done because intra syngen micro-injections of mitochondria are 
usually much more successful than intersyngen micro-injections. 
Drug selection: After iniero- injcctiomi. cells were transferred to bacterized medium and after 
one fission at 18° C (iii the absence of erythroniyciu) were transferred singly to medium con-
taining 250 [eg/nil erythromycin and incubated at 25° C. 
Extends !or eiectrophoresi.s: 250 ml cultures of stocks were concentrated by centrifugation 
and the pelleted cells homogenised as previously described (Tait, !970a). 
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Fig. 1. Transfer of niitochondria by micro-injection between different syngens. showing the 
origin of the syngen 1/7 "hybrid" 
Results 
Syngen 7 sensitive cells were micro-injected with mitochondria prepared from 
syngen 1 resistant cells and after 3 weeks of incubation at 250  C in erythromycin-
containing medium, 2 out of a total of 40 microinjectecl syngen 7 sensitive cells 
became resistant. None of the 96, un-injected syngen 7 sensitive controls became 
resistant. It should be noted that the transfer of resistance by micro-injection 
between resistant and sensitive stocks of the same syngen is usually 70-100%. 
(Beale et at., 1972). Thus the transfer of resistance implies, firstly, that the mito-
chondrial genome of syngen I is able to be incorporated into a cell containing a 
syngen 7 nucleus as shown in Fig. 1. Secondly, the considerable drop in the per-
centage intersyngen resistance transfer as compared to intrasyngen suggests that 
there are differences between the mitochondria of the two syngens. 
The use of this technique for determining the nuclear or mitochonchial control 
of specific initochondrial proteins requires the presence of intersyngen mito-
chondrial protein differences. It is known that syngens 1 and 7 differ as regards the 
electrophoretic mobility of fumarase (Tait, 1970a) and so the mitochondrial or 
nuclear location of the genetic control of this enzyme can be determined using 
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Fig. 2. Starch gel zymogram of fumarase, showing electrophoresis of extracts from syngen I 
(168EIt), syngen 7 (227) and syngen 7 cells micro-injected with syngen 1 erythromycin resistant 
mitochondria (7/1). Electrophoresis was carried out for 3 hours at 00  C in a 0.01 Al phosphate-
citrate buffer pH=5.5. Enzyme activity was localised by overlaying the gel with 30 mIs of 
staining solution (3.9 mg/nil sodium fumarate. 0.25 mg/ml NAD, 0.2 ing/mI MTT-tetrazolium, 
0.02 mg/ml PMS and 1 i.u. malic dehydrogenase in (Li M phosphate buffer pH=7.4) and 
incubating at 35° C 
the micro-injected syngen 7 clones. Extracts from cells of stocks 168 Elt, 227 and 
7/1 (syngen 7 cells made resistant by micro-injection of erythromycin resistant 
mitochondria from 168E) were made and then subjected to starch gel eleetropho-
resis, followed by staining the gels for fumarase activity. As can be seen in Fig. 2, 
the "hybrid 7/1" stock shows a band of fumarase activity identical in mobility 
to that of syngen 7. This result establishes that fumarase is not controlled by the 
mitochondrial genome and by inference must be controlled by the nuclear genome. 
conclusion—Discussion 
Certain soluble mitochondrial enzymes have been shown to be controlled by 
nuclear genes in both Paramecium (Tait, 1968; Tait, 1970b) and other organisms 
(Munkres et al., 1965; Munkres and Woodward, 1967; Davidson and Cortner, 
1967; Longo and Scandalios, 1969; Davidson et al., 1970) using within-species 
genetic analysis. The result presented in this paper provides further evidence for 
the idea that most or possibly all the soluble mitoehondrial enzymes are controlled 
by the nuclear genome, but uses a new method for establishing the localisation of 
the genetic control. 
The more general application of this technique of micro-injection for deter-
mining the control of specific mitochondrial proteins will depend on the elucidation 
of further intersyngen differences in mitochondrial proteins; fumarase is the only 
mitochondrial protein so far shown to have different forms in syngen 1 and syngen 
7 cells. However, as only 5 enzymes (glutamate dehydrogenase, succinate dehy-
drogenase, fl-hydroxybutyrate dehydrogenase, iso-citrate dehydrogenase and 
fumarase) have been compared so far, it is reasonable to expect that further 
differences will be observed when more proteins are examined. This type of study 
is being undertaken at the present time. 
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The aquisition of erythromycin-resistance by the micro-injected syngen 7 
sensitive cells could occur by a number of mechanisms which must be considered 
before we can definitely state that syngen I mitochondria are able to replicate in 
a syngen 7 cell. Three possible mechanisms can be considered: 
the syngen 7 resistant clones arise by spontaneous mutation; 
the syngen 7 mitochondria aquire the resistance by ''recombination'' with 
the micro-injected syngen 1 erythromycin resistant mitochondria, by a 
mechanism involving the incorporation of an cryt.hromycin-resistant 
"gene" from syngen 1. 
the syngen 7 sensitive mitochondria are eliminated by erythromycin and 
the syngen 1 resistant mitochondria replicate to produce mitochondria with 
their nuclear component from syngen 7 and their mitochondrial component 
from syngen 1. 
The possibility that the syngen 7 cells aquire resistance by spontaneous mu-
tation (i) can be eliminated since it is known that the spontaneous mutation rate 
is of the order of 1 per 1 000 cells and this is confirmed by the absence of ciythromy. 
cm-resistant cells amongst the un-injected controls, compared to the higher fre-
quency of aquisition of resistance following micro-injection (1 in 20 cells). 
The reduction in frequency of transfer of erythromycin resistance from 
70-100% in intrasyngen experiments to about 5% in intersyngen experiments 
might be explained by a requirement for recombination in intersyngen transfers. 
Two pieces of evidence make recombination an unlikely possibility. Repeated 
attempts to obtain recombination between erythromycin and chloramphenicol 
resistant markers in syngen 4 (Beale et al., 1972: Adoutte and Beisson, 1972) have 
been made but no recombination has been obtained. This is in marked contrast to 
results obtained with yeast (Thomas and Wilkie, 1968: Coen et al., 1970; Wilkie, 
1970) where recombination between similar markers can be obtained readily. The 
negative results with Paramecium suggest that mitochondrial recombination 
between these two markers occurs extremely rarely, if at all, in Paramecium and 
suggests that recombination may be a rare event in general. 
Preliminary results with resistance transfer between syngens I and 5 shows a 
similar lowered percentage of transfer of resistance when syngen 1 resistant mito-
chondria are micro-injected into syngen 5 sensitive cells. When resistant mi-
tochondria, prepared from the "hybrid" svngen 1/5 resistant cells are micro-
injected into syngen 1 sensitive cells, 70-100% transfer of resistance is observed. 
This implies that the syngen 1 resistant mitochondrial genome is unchanged after 
replicating within the syngen 5 cell. If resistant mitochondria are prepared from 
the syngen 1 cells which have been previously micro-injected with mitochondria 
from the "hybrid" svngen 1/5 cells and then micro-injected back into syngen 5 
sensitive cells, the same lowered percentage transfer of resistance is observed as 
that observed initially. If recombination between the mitochondrial genornes of 
syngens 1 and 5 had occurred one would expect an increased percentage resistance 
transfer back into syngen 5. Further work is in progress to establish these findings 
more definitely. 
Thus, the most likely explanation for the results described here is that the 
whole syngen I mitochondrial genome is transferred into syngen 7 cells. The re-
duced frequency of transfer is possibly due to the interaction of the syngen 7 
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nuclear genome and the syngen I rnitochondrial genorne. it is hoped that by ex-
tending the search for mitoehondral protein differences between svngens, this 
approach will provide a valuable contribution to the elucidation of the informa-
tional content of mitochondrial DNA. 
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Summary. Mitochondria from one syngen (or sub-species) of f'arameciunt aureiw have 
been introduced into a different syngen by preparing erythromycin-resistant mitochondria 
from syngen 1 and micro-injecting them into erythromycin-sensitive syngen 7 cells. The reci-
pient sensitive cells were then placed in erythromycin to inhibit the replication of the sensitive 
mitochondria. Such selected clones contain a syngen 7 nucleus bitt a mitoehondrial genonie 
which is derived from syngen I erythromycin-resistant mitochondria. 
Using this method it has been shown that the mitochondrial enzyme fumarase is not coded 
by the mitochondrial genome, and by implication, is coded by the nuclear genome. The use of 
this technique as a method for determining if specific mitochondrial proteins are controlled 
by nuclear or mitochondrial genes is discussed. 
Introduction 
It is now well established that mitochondria contain DNA (Borst and Kroon, 
1969; Ashwell and Work, 1970; Borst, 1972), but many of the specific functions 
of this DNA remain to be determined. Hybridization studies with mitochondrial 
ribosomal RNA and transfer RNA have shown that mitochondrial DNA codes for 
these molecules (Borst and Aaij, 1969; Nass and Buck, 1970; Attardi et at., 1970; 
Borst and Grivell, 1971 ; Aloni and Attarcli, 1971 a, b and c). In animal mito-
chondria the RNA-DNA hybridization plateaus indicate that 20-250 '0 of the total 
genomc codes for the mitochondrial ribosomal and transfer RNA (Borst, 1972). It 
seems likely that the remaining DNA sequences code for certain mitochondrial 
proteins and several experimental approaches are available for investigating which 
mitochondrial proteins are involved. These approaches can be summarised as 
follows (Borst, 1972): 
amino acid incorporation into mitochondrial proteins in the presence of 
inhibitors of mitochondrial or cytoplasmic protein synthesis, followed by 
identification of the labelled products; 
analysis of the proteins labelled when isolated mitochondria are incubated 
with labelled amino acids; 
identification of mitochondrial proteins synthesised in the absence of 
mitochondrial DNA in petite mutants with no rn-DNA; 
identification of altered proteins in drug resistant, cytoplasmically in-
herited mutants. 
Evidence supplied by these approaches is often difficult to interpret unambi-
guously (Nass, 1969; Ashwell and Work, 1970: Rabinowitz and Swift, 1970; 
Kroon and de Vries, 1970; Borst and Grivell, 1971; Mahler et at., 1971). In the 
case of approaches (i) and (ii) the synthesis of certain proteins may depend on 
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components from both nuclear and mitocliondrial genomes, so that one may under-
estimate the number of proteins coded for by the nucleus or mitochondria. Also, 
mitochondrial messenger RNA may be translated on cytoplasmic ribosomes or 
nuclear messenger RNA may be translated on mitochondrial ribosomes and this 
would confuse the interpretation of these results. Using petite cells, describer! in 
(iii), the mitochondria are grossly altered and some of the proteins coded for by 
the nucleus may depend on a complete mitochondrial structure for incorporation 
and synthesis. The major disadvantage of approach (iv) is the limited number of 
drugs and resistant mutants which are available; this approach also requires that 
crosses can be made between resistant and sensitive cells. 
The approach described in this paper does not depend on the use of extensively 
altered mitochondria or drug inhibited systems. Cytoplassnically inherited cry- 
thromycin-resistant mutants have been obtained in Paramecium (Beale, 1969; 
Adoutte and Beisson, 1970) and evidence has been obtained, showing that the 
mutation is mitochondrial (Beale et al., 1972). In the present study, the original 
sensitive mitochondrial population of a cell has been replaced by an erythromycin-
resistant population of mitochondria, derived from a sub-species which is sexually 
isolated from the recipient cell. This approach allows the study of clones which 
derive their mitochondrial genome from one syngen (or sub-species) and their 
nuclear genome from another. Intersyngenic variation of mitochondrial proteins 
allows the localisation of the genetic information for a variant protein to be made 
by micro-injection of mitochondria between sexually isolated sub-species. 
Fumarase has been shown to differ in electrophoretic mobility between syngens 
(Tait, 1970a) and in this paper, this difference is used to show that fumarase is 
controlled by the nuclear genome. 
Materials and Methods 
Stocks: stocks 168 (syngen 1), 227 (syngen 7) and the spontaneous erythromycin resistant 
mutant 168 E (Edin), derived from 168, of Paramecium aurelia were used. The mutant stock 
grows at normal rate in 250 _tg/ml of erythromycin. 
Cultures: stocks were cultured on a grass infusion, buffered with phosphate, and bacterized 
with _4erobacter aerogenes (Sonneborn, 1950) at 25° C. 
Mitochondria: 10 L. cultures of Paramecium were filtered through cotton wool and the 
cells pclletedby continuousfiow centrifugation at a flow rate of 700ml/min at 500g. The packed 
cells were resuspended in Dryl's solution and pelletecl by centrifugation at 1500 r.p.m. for 
4 mm. in an M.S.E. oil-testing centrifuge. The pehleted cells were disrupted in 10 volumes of 
buffeted raffinosc (Preer 1959) by homogenisation in a cream homogeniser. Mitochondria were 
then prepared by differential centrifugation as previously described (Beale et al, 1972). 
Micro-injection: The technique used was essentially that of Koisumi and Preer (1966) but 
with modifications to be described elsewhere (Knowles, in press). A thick suspension of inito-
ehondriaprepared from resistant syngen 1 cells was micro-injected into single sensitive syngen 
7 cells. The viability of the mitochondrial preparation was estimated by injecting it into sen-
sitivesyngen 1 cells. This was done because intra syngen micro-injections of mitochondria are 
usually much more successful than intersyngen micro-injections. 
J)rug selection: After micro-injection, cells were transferred to bacterized medium and after 
one fission at 18° C (in the absence of erythromycin) were transferred singly to medium con-
taining 250 g/ml erythromycin and incubated at 25° C. 
Extracts for elect rop/wrests: 250 ml cultures of stocks were concentrated by centrifugation 
and the pelleted cells homogenised as previously described (Tait, 1970a). 
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Fig. 1. Transfer of mitochondria by micro-injection between different syngens, showing the 
origin of the syngen 1/7 "hybrid" 
Results 
Syngen 7 sensitive cells were micro-injected with mitochondria prepared from 
syngen 1 resistant cells and after 3 weeks of incubation at 2° C in erythrornycin-
containing medium, 2 out of a total of 40 microinjeeted syngen 7 sensitive cells 
became resistant. None of the 96, un-injected syngen 7 sensitive controls became 
resistant. It should be noted that the transfer of resistance by micro-injection 
between resistant and sensitive stocks of the same syngen is usually 70-100%. 
(Beale et al.. 1972). Thus the transfer of resistance implies, firstly, that the mito-
chondrial genome of syngen 1 is able to be incorporated into a cell containing a 
syngen 7 nucleus as shown in Fig. 1. Secondly, the considerable drop in the per- 
centage inters 	resistance transfer as compared to intrasyngen suggests that 
there are differences between the mitochondria of the two syngens. 
The use of this technique for determining the nuclear or mitoehondrial control 
of specific mitochondrial proteins requires the presence of intersyngen mnito-
chondrial protein differences. It is known that syngens 1 and 7 differ as regards the 
electi'ophoretic mobility of fumarase (Tail, 1970a) and so the mitochondrial or 
nuclear location of the genetic control of this enzyme can be determined using 
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Fig. 2. Starch gel zymogram of fumarase, showing electrophoresis of extracts from syngen 1 
(168E), syngen 7 (227) ancisyngen 7 cells micro-injected with syngen I erythromycin resistant 
mitochondria (7/1). Electrophoresis was carried out for 3 hours at 0° C in a 0.01 M phosphate-
citrate buffer p11=5.5. Enzyme activity was localised by overlaying the gel with 30 mis of 
staining solution (3.9 mg/mI sodium fumarate, 0.25 mg/ml NAJ), 0.2 mg/ml MTT-tetrazolium, 
0.02 mg/ml PMS and I lu. inalic dehydrogenase in 0.1 M phosphate buffer p11=7.4) and 
incubating at 35° C 
the micro-injected syngen 7 clones. Extracts from cells of stocks 168E, 227 and 
7/1 (syngen 7 cells made resistant by micro-injection of erythromycin resistant 
mitochondria from I 68E) were made and then subjected to starch gel electropho- 
resis, followed by staining the gels for fumarase activity. As can be seen in Fig. 2, 
the "hybrid 7/I " stock shows a hand of fumarase activity identical in mobility 
to that of syngen 7. This result establishes that fumarase is not controlled by the 
mitochondrial genome and by inference must be controlled by the nuclear genome. 
Conclusion—Discussion 
Certain soluble mitochondrial enzymes have been shown to be controlled by 
nuclear genes in both Paramecium (Tait, 1968; Tait, 1970b) and other organisms 
(Munkres et al., 1965; Munkres and Woodward, 1967; Davidson and Cortner, 
1967; Longo and Scandalios, 1969; Davidson et at., 1970) using within-species 
genetic analysis. The result presented in this paper provides further evidence for 
the idea that most or possibly all the soluble mitochondrial enzymes are controlled 
by the nuclear genome, but uses a new method for establishing the localisation of 
the genetic control. 
The more general application of this technique of micro-injection for deter- 
mining the control of specific mitochondrial proteins will depend on the elucidation 
of further intersyngen differences in mitochondrial proteins; fumarase is the only 
mitochondrial protein so far shown to have different forms in syngen 1 and syngen 
7 cells. However, as only 5 enzymes (glutamate dehyclrogenase, succinate clehy-
drogenase, iJ-hydroxybutyrate dehycirogenase, iso-citrate dehydrogenase and 
fumarase) have been compared so far, it is reasonable to expect that further 
differences will be observed when more proteins are examined. This type of study 
is being undertaken at the present time. 
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The aquisition of erythroniycin-resistanee by the micro-injected syngen 7 
sensitive cells could occur by a number of mechanisms which must be considered 
before we can definitely state that syngen 1 mitochondria are able to replicate in 
a syngen 7 cell. Three possible mechanisms can be considered: 
the syngen 7 resistant clones arise by spontaneous mutation 
the syngen 7 mitochondria aquire the resistance by "recombination" with 
the micro-injected syngen 1 erythromycin resistant mitochondria, by a 
mechanism involving the incorporation of an erythromycin-resistant 
"gene" from syngen 1. 
the syngen 7 sensitive mitochondria are eliminated by erythromycin and 
the syngen 1 resistant mitochondria replicate to produce mitochondria with 
their nuclear component from syngen 7 and their mitochondrial component 
from syngen 1. 
The possibility that the syngen 7 cells aquire resistance by spontaneous mu-
tation (i) can be eliminated since it is known that the spontaneous mutation rate 
is of the order of 1 per 1000 cells and this is confirmed by the absence of erythromy-
cin-resistant cells amongst the un-injected controls, compared to the higher fre-
quency of aquisition of resistance following micro-injection (1 in 20 cells). 
The reduction in frequency of transfer of erythromycin resistance from 
70-100% in intrasyngen experiments to about 50/'0 in intersyngen experiments 
might be explained by a requirement for recombination in intcrsyngen transfers. 
Two pieces of evidence make recombination an unlikely possibility. Repeated 
attempts to obtain recombination between erythromycin and chloramphenicol 
resistant markers in syngen 4 (Beale et al., 1972; Adoutte and Beisson, 1972) have 
been made but no recombination has been obtained. This is in marked contrast to 
results obtained with yeast (Thomas and Wilkie, 1968: Coen et at., 1970 Wilkie, 
1970) where recombination between similar markers can be obtained readily. The 
negative results with Paramecium suggest that mitochondrial recombination 
between these two markers occurs extremely rarely, if at all, in Paramecium and 
suggests that recombination may be a rare event in general. 
Preliminary results with resistance transfer between syngens 1 and 5 shows a 
similar lowered percentage of transfer of resistance when syngen 1 resistant mito-
chondria are micro-injected into syngen 5 sensitive cells. When resistant mi-
tochondria, prepared from the "hybrid" syngen 1/5 resistant cells are micro-
injected into syngen 1 sensitive cells, 70-100 0% transfer of resistance is observed. 
This implies that the syngen 1 resistant mitochondrial genome is unchanged after 
replicating within the syngen 5 cell. If resistant mitochondria are prepared from 
the syngen 1 cells which have been previously micro-injected with mitochondria 
from the "hybrid" syngen 1/5 cells and then micro-injected back into syngen 5 
sensitive cells, the same lowered percentage transfer of resistance is observed as 
that observed initially. If recombination between the mitochondrial genomes of 
syngens 1 and 5 had occurred one would expect an increased percentage resistance 
transfer back into syngen 5. Further work is in progress to establish these findings 
more definitely. 
Thus, the most likely explanation for the results described here is that the 
whole syngen 1 mitochondrial genome is transferred into syngen 7 cells. The re-
duced frequency of transfer is possibly due to the interaction of the syngen 7 
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nuclear genome and the syngen I mitochondrial geriome. It is hoped that by ex 
tending the search for mitochondrial protein differences between s ngens, this 
approach will provide a valuable contribution to the eluedation of the informa-
tional content of mitochondrial DNA. 
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24. 
Results 
Part I: Preliminary studies on thejtion of erythromycin resistance 
in Paramecium aurelia by microinjection. 
1. 	To find out if it was possible to transfer this resistance by 
microinjection a 500 g. supernatant from a homogenised preparation 
of erythromycin resistant cells was injected into sensitive cells. 
This supernatant contained most cell components except for macronuclei 
and large pieces of pellicle. However initial experiments were 
unsuccessful until the developments in the technique of microinjection 
described in the last section allowed the routine use of injection 
needles with larer internal diameters, 
TabJ.e 1 shows the number of cells becoming resistant 
following microinjection with a 500 g. supernatant Of the 42 cells 
surviving injection, 22 developed resistance to erythromycin. 







21.10.70. 8 1 12 
2210.70. 8 4 50 
29.10.70. 6 3 50 
12.11.70. 20 14 70 
25. 
It should be noted that positive results were only obtained following 
the use of an injection needle with an internal diameter of not less 
than 2.8 microns, and that this corresponds well to the size of the 
mitochondria of paramecium (2-4 microns). 
The Development of Resistance 
When cells sensitive to erythromycin are placed in bacterised slide 
medium containing 250 mg/ml erythromycin, they are unable to divide 
beyond one or two residual fissions. However, these organisms are 
not killed for some 2 to 4 weeks. During this period thci grow 
slowly and become black and thin. Drug resistant mutants grow at 
the normal rate in the presence of erythromycin. 
Sensitive cells injected with a cytoplasmic extract 
derived from resistant cells develop resistance in a very characteristic 
way. Initially they appear to be sensitive to erythromycin. After 
a variable period of time the cells pass through an intermediate 
stage, lasting about 12 hours, when they are unusually pear shaped 
and fast swimming. After this the cell resumes normal growth in 
the presence of erythromycin and is then classified as having 
developed resistance. 
2. 	In an attempt to purify the cellular fraction conferring 
ristrce to erythromycin a procedure using a cushion of 50% sucrose 
in deuterium oxide was developed. This procedure produced a purer 
preparation 
mitochonc'riaijthan that obtained with a 5,000 g. pellet and had the 
advantage of not requiring the prolonged presence of high sucrose 
Concentrations necessitated by the use of equilibrium gradients. 
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Figure 2: This shows a section of an osmium fixed pellet of 
mitochondria 	oared on a sucrose step gradient. 
Most mitochondria are swollen. 	(X 20,000). 
M 
26. 
However, it was found that these preparations were unable to 
transfer erythromycin resistance to sensitive cells (Table 2). 
TABLE 2: Development of resistance in cells injected with mitochondria 
from D 0O interface. 
Total number 
Date 	surviving 	injection 	 Number Resistant 
	
19.11.70. 	 9 	 1 
20.11.70. 	 18 	 0 
3.12.70. 	 9 	 0 
L - 
36 cells were injected with this t;pe of preparation and only one developed 
resistance to erythromycin.Iilrthermore,these preparations were often lethal 
on injection unless diluted because of the high concentration of sucrose 
present. 
An electron microscope examination of a preparation of this type 
showed that although there was little contamination by other cell components, 
the mitochondria appeared very much more swollen and damaged as compared to 
(Fig. 2) 
mitochondria fixed in vivoi It was felt that these structural changes 
produced by preparing mitochondria in 50% sucrose might well affect the 
ability of this preparation to transfer resistance to erythromycin. 
3. 	This failure of mitochondria prepared in 50% sucrose to transfer 
resistance to erythromycin following microinjection prompted the use of a 
second method for the preparation of mitochondria. This second method was 
developed by Preer and Preer (1959) with the modification described earlier. 
27. 
This method has the advantage of being very rapid, and it does not expose 
the mitochondria to high concentrations of sucrose. Of the 20 cells 
injected in the first experiment using this type of preparation, 18 of 
these cells became resistant to erythromycin. Table 3 shows the 
experiments in which this type of preparation was used. .iZ% of the 
cells injected with this type of mitochondrial preparation developed 
resistance to erythromycin. 
TABLE 3: Development of resistance in cells injected with mitochondrial 






9.12.70. 20 18 
5. 	6.71. 9 7 
5. 6.71. 7 4 
19. 	6.71. 11 9 
20. 6.71. 5 2 
24. 	6.71. 13 13 
5. 7.71. 8 7 
6. 	7.71. 8 2 
9. 7.71. 5 4 
6.10.71. 11 11 
8.10.71. 8 8 
9.10.71. 4 4 
21.10.71. 7 3 
23.10.71. 9 
9.11.71. 7 5 
7. 	7.72. 12 12 
5. 7.72. 18 8 
30. 	6.72. 24 24 
25. 6.72. 13 13 
2. 	2.72. 17 17 
15. 2.72. 16 12 
Total 232 191 
191 /232 = 82% develop resistance. 
Pacing Page 28. 
Figure 3: This shows a section ofosmium/pellet of a mitochondrial 
preparation. Note that many mitochondria are highly 
condensed. 
in - mitochondria 	 sin - swollen mitochondria 




(a) 	Cells were injected with a post-mitochondrial (5000 g) supernatant. 
Of the 14 cells injected with this cell fraction none developed resistance 
to erythromycin. 
To show that acquisition of erythromycin resistance is not just 
an artefact of injection, sensitive cells were injected with a preparation 
of mitochondria from the same clone of sensitive cells. Of the 36 cells 
injected with this preparation, none became resistant. 
Further, of the 1,120 uninjected control cells derived from the 
same clone as and treated in an identical manner as those injected, not 
one became resistant. 
The purity of mitochondrial preparations 
An attempt was made to obtain information about the purity of 
mitochondrial preparations used for microinjection by the examination 
of pellets of these preparations in the electron microscope (Fig. 3). The 
frequencies of the various components are shown in Table 4. 
TABLE 4. The relative numbers of different components in mitochondrial 






"Normal" condensed mitochondria 899 68 84 
Swollen mitochondria 166 12 16 
Trichocysts 50 4 
Bacteria 144 11 
Membranes 51 3.5 
Cilia 20 1.5 
29. 
It was found that mitochondria made up 80% of the total and could be 
classified into two classes (Pig.3). 
Highly condensed mitochondria with a dense matrix, making 
up 68% of the total, and, 
Swollen mitochondria with a clear matrix, being 12% of the 
total. Many of these had incomplete inner and outer membranes and 
some were completely ruptured. 
Observation of the mitochondrial preparation by light microscope 
at periods of up to 7 hours after homogenisation showed an increase 
in the number of swollen translucent mitochondria. 	It is probable 
that these swollen translucent mitochondria are incapable of trans-
mitting msistanceto erythromycin. 
The major contaminant was bacteria which comprised nearly 1176 
of the total. Other contaminants present were trichocysts, both 
exploded and unexploded (4%), Various membranes largely derived 
from either the pellicle or from the endoplasmic reticulum (4%) and 
cilia (1.5%). 
30. 
Part II. The Effect of DNAse RNAse and Detergent on the ability 
of mitochondrial preparations to transfer resistance to 
erythromycin. 
This section describes the effects of nucleases and detergents 
on the ability of mitochondrial preparations to transfer resistance to 
erythromycin to sensitive cells by microinjection. 
(1) Treatment with Detergent 
When a mitochondrial preparation was treated with 1.576 Triton 
X 100 for 30 minutes at 0°C prior to injection, it was found that none 
of the 15 cells injected with this preparation developed resistance. 
In contrast, all 13 of the cells injected with a similar but untreated 
control preparation did become resistant to erythromycin. Light 
microscope observation of the treated preparation showed that very 
few mitochondria-like bodies were still visible. 
This result shows clearly that even relatively low concentrations 
of non-ionic detergent completely remove the ability of mitochondrial 
preparations to transfer resistance. 
(2) Treatment with DNAse 
The treatment of mitochondrial preparations with 1 mg/ml of DNAse 
II for 1.5 hours at 00C prior to microinjection was found to have no 






Facing Page 31. 
Figure 4: This shows the decrease in T.C.A. precipitable counts with 
time when 14C DNA is incubated with 1 mg/ml DNAse in 
rafinose homogenization buffer - . - . - 0, and when 
14 C RNA is incubated with 1 mg/ml RNAse in rafinose 
homogenization buffer 	I 	. The closest 
approach to a straight line was achieved by a semi log 
plot. 
31. 
measurable effect on transmission of erythromycin resistance to 
sensitive cells. Of the 28 cells injected with this preparation, 26 
developed resistance. In the control group injected with a similar 
untreattd preparation, 28 out of 31 cells developed resistance. 
(3) Treatment with RNAse 
The treatment of a mitochondrial preparation with 1 mg/ml of 
RNAse for 1 hour at 0°C was also found to produce no measurable 
effect on the transmission of erythromycin resistance. Of the 37 
cells injected with treated preparations of mitochondria, 31 cells 
became resistant, of 33 cells injected with the control preparation 
29 developed resistance. 
As the composition of the mitochondrial isolation buffer is not 
similar to that of solutions used to assay the activity of nucleases, 
experiments were carried out to estimate the catabolic activity of the 
two nucleuases in the isolation buffer. Radioactive polyribo- or 
deoxyribonucleic acids, and the relevant nuclease were incubated 
in the isolation buffer and the rate of degradation estimated by 
counting trichioroacetic acid precipitable radioactivity at various 
times. These results are plotted in Fig.4. 
These graphs show that the amount of TCA precipitable radio-
active DNA is reduced by one half in 45 minutes and the amount of 
radioactive RNA is reduced by one half in 30 minutes. 
32. 
These results show that the factor confirming resistance to 
erythromycin is not affected by DNAse or RNAse but is completely 
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Figure 5: This shows the time taken for cells injected with 
different numbers of mitochondria to develop resistance. 
Cells injected with: 	 more than 50 mitochondria. 
- - a mean of 5 mitochondria 
per injection. 
a mean of 1 mitochondria 
per injection. 
33. 
Part [IX. The effects of injecting small numbers of mitochondria 
into single cells. 
(1) The effect of injecting different numbers of mitochondria on the 
time taken to develop resistance. 
It should be noted that the results to be discussed here are 
preliminary and can at best only give an indication of the effects 
of injecting small numbers of mitochondria into cells. 
If the development of resistance to erythromycin following 
microinjection of a sensitive cell is defined as having occurred 
when the number of cells in any depression exceeds twelve, it is 
possible to record with an accuracy of + 24 hours the time taken to 
develop resistance. In these experiments the initial concentration 
of mitochondria was estimated by means of a special counting chamber 
and the orinal preparation diluted to give a mean of one or five 
mitochondria per injection. Figure 5 and Table 5 show the time in 
days for cells to develop resistance following injection with either 
a mean of 1 or 5 mitochondria per injection. The control cells shown 
are those cells injected with between 50 and 100 mitochondria per 
injection. 
34. 
TABLE 5: The time taken for cells injected with different numbers 
of mitochondria to develop resistance. 





4 	 9 
5 56 	 2 
6 	 23 
7 23 	 4 
8 	 7 12 
9 5 	 5 	 7 
10 	 0 3 
11 3 	 2 
12 	 1 
13 	 2 	 1 
14 1 
15 	 1 
16 1 




The median time taken for cells injected with a mean of one mito-
chondria to develop resistance is 9 days, whereas cells injected with an 
average of 5 mitochondria develop resistance in a median time of 8 days. 
The control cells injected with more than 50 mitochondria have a median 
time of 5 days required to develop resistance. 
35. 
Although preliminary, these results indicate that the time taken 
by a cell to develop resistance is roughly proportional to the absolute 
numbers of mitochondria from a resistant strain injected into that 
cell. 
(2) The effect of the numbers of mitochondria injected on the frequenc 
of development of resistance. 
Of the 35 surviving cells injected with a mltochondrial preparation 
diluted to give an average of 1 mitochondriO),per injection, a total of 
10 became resistant 
Of the 38 surviving cells injected with a preparation diluted to 
give 5 mitochondria per injection a total of 26 developed resistance. 
Results already presented (Table 3) show that on average 82% 
of the cells injected with more than 50 mitochondria develop 
resistance. 
The significance of these results should be examined by 
comparing them with the expectations for the number of "successes" 
derived from a poion distribution and this will be discussed fully 
in the next (Discussion) section. 	However, they do suggest that 
very few mitochondria are required to change the phenotype of a 
sensitive cell to erythromycin resistance. 
36. 
Discussion 
The aim of the work presented in this chapter was to locate 
the site of cytoplasmically inherited erythromycin resistance in 
Paramecium aurelia. 
The evidence presented in Section I of the Results shows 
that the cell fraction most efficient at transferring resistance to 
erythromycin to sensitive cells was the mitochondrial fraction 
prepared by differential centrifugation. It was shown by electron 
microscope observations of sectioned aitochondrial pellets that 
these preparations contained about 80% mitochondria. The major 
contaminant was bacterial, but the bacteria in these preparations 
had never been exposed to erythromycin and were found to be 
sensitive to erythromycin (West, unpublished). 
Attempts to induce development of erythromycin resistance 
by injection with purer fractions of mitochondria prepared with 
sucrose step gradients were unsuccessful. This failure was 
probably due to damage to mitochondria caused by the high concen-
trations of sucrose used. Rat liver mitochondria are partially 
disrud by the hydrostatic pressure produced during rapid centri-
fugation (Wattiaux et al., 1971), and a similar effect may also have 
damaged Paramecium mitochondria prepared: on sucrose step gradients. 
Examination of sections of mitochondrial pellets produced by sucrose 
step gradients showed that the mitochondria appeared very much more 
disrupted than those prepared by differential centrifugation. 
37. 
In Neurospora, Diakumacos et al. (1965) were able to obtain 
transmission of a cytoplasmic character causing slow growth, abn 1, by 
niicroinjecting abn 1 aitochondria prepared on a continuous sucrose 
gradient into normal hyph. It seems likely that there are differences 
in the sensitivity of mitochondria from Paramecium and Neurospora 
to high osmotic and hydrostatic pressures and this may be due in part 
to the two-fold differences in niitochondrial size between these 
species. 
Examination by electron microscopy of fixed pellets of mitochondria 
prepared by differential centrifugation showed that the great majority 
of these mitochondria were very much more condensed than mitochondria 
examined in sections of whole cells. Hakenbrook (1968, 1972), Penniston 
et al. (1967) and Green and Harris (1969) have shown that inhibition 
of certain parts of oxidative phosphoration in rat liver mitochondria 
produces a condensed and densely staining matrix. The extremely 
condensed appearance of mitochondria in the preparations used for 
microinjection may be due to inhibition of part of oxidative 
phosphorolation by the low oxgen tension in these concentrated 
suspensions of mitochondria. However, this abnormal physiological 
condition does not seem to affect the ability of these organdies to 
transfer resistance to erythromycin into sensitive cells. 
Part II of the Results presents evidence that neither DNAse nor 
RNAse appears to have any measurable effect on the ability of 
mitochondrial preparations to transfer resistance to erythromycin, 
while low concentrations of Triton X 100 completely removed this 
ability. 
3,. 
If the determinant for erythromycin resistance is located on 
the mitochondrial DNA, the nucleases would not be expected to have 
an effect on the transmission of erythromycin resistance, because 
this DNA is protected by the mitochondrial membranes. Plavell and 
Jones (1971) have shown in Paramecium that there is little reduction 
in the amount of mitochondrial DNA obtained when the mitochondria are 
pretreated with DNAse. 
The primary effect of the detergent appears to be the destruction 
of the gross structure of the mitochondria. Whether the whole 
structure of the mitochondria is required for transmission of erythro-
mycin resistance is not known, as it is possible that the mitochondrial 
DNA is rapidly degraded on the breakdown of the mitochondrial membranes. 
The inability of nucleases to affect the transmission of erythromycin 
resistance does rule out the possibility that this transmission is 
caused by extra-mitochondrial DNAs or RNAs bound to the surface of 
the organelle. 	It is of interest to note that the use of a needle 
with an internal diameter too small to allow passage of whole mitochondria 
also prevents transmission of resistance to sensitive cells 	fithough 
the injection of normal quantities of fluid occurs. 
Part III of the Results present preliminary evidence suggesting 
that only one mitochondricimay be required to transform a previously 
sensitive cell to erythromycin resistance. However, in the analysis 
of these results the following three factors should be taken into 
account. 
1) Only about 84% of the mitochondria present in mitochondrial 
preparations are structurally intact as judged by examination of 
their membranes in the electron microscope. 
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mean no. of mitochondria-like bodies per injection 
Figure 6: 	These graphs show the percentages of the total number 
of cells injected which would be expected to develop 
resistance if one ( 	), two C— . - . —), and 
three C -----) mitochOndria were sufficient to 
transfer erythromycin resistance for a given mean number 
of mitochondria per injection. The two experimental 
results are also shown with + 1.96 standard deviation 
errors. 
39. 
It is difficult to distinguish between Kiebsiella aerogenes, 
the food organism, and Paramecium mitochondria with a light tuicroscope. 
These two factors make estimates of the number of mitochondria 
capable of transmitting resistance to erythromycin at least 15% too 
high. 
Even in experiments where sensitive cells are injected with 
more than 50 mitochondria per injection only 82% of these become 
resistant. Therefore, any estimate of success should be modified 
such that the maximum possible success is 82%. 
As the volume of the mitochondriO1is of the order of 10 of 
the volume injected into each cell, it is reasonable to assume that 
the presence of one mitochondria has negligible effect on the presence 
or absence of any other. A poisson distribution may therefore be 
used to predict the proportion of injections which transfer at least 
ore, at least two, at least three, .... etc. mitochondria for a given 
mean number of mitochondria per injection. Figure 6 shows a graph of 
three curves each one representing the percentage of cells receiving 
at least 1, at least 2, and at least 3 mitochondria per injection for a 
range of mean numbers of mitochondria per injection. The poisson 
expectations on the graph have been modified in the following way: 
Factor 1 (0.84) and Factor 2 (0.90) affect the mean number of 
"viable" mitochondria per injection and so this mean number is 
divided by 0.84 x 0.90. Factor 3 reduces the expectation of success 
and so is applied to the probability that a particular cell will 
receive at least 1, 2 or 3 mitochondria. 
40. 
It should be noted that these three factors represent only those 
effects which are roughly quantifiable, and so the modified expectations 
are probably still an overestimate of the number of cells expected 
to develop resistance. 
When the two preliminary results obtained so far are plotted on 
this expectation graph they both fell between at least 1 and at least 
3 mitochondria required to transfer resistance to erythromycin. This 
evidence shows that only a very few mitochondria are required to 
transfer erythromycin resistance to a sensitive cell. If this 
finding was confirmed it would provide conclusive evidence that most 
if not all the mitochondria in one cell were genetically equivalent 
with respect to erythromycin resistance. 
In summary, by microinjection of various cell fractions into 
sensitive cells it has been shown that erythromycin resistance is 
located in the mitochondria, probably on the mitochondrial DNA. 
The possibility that some other cell fraction could be responsible for 
transmitting erythromycin resistance has been ruled out for two 
reasons. Firstly, the post-mitochondrial supernatant was shown to be 
unable to transmit erythromycin resistance to sensitive cells. 
Secondly, while low concentrations of non-ionic detergent completely 
removed the ability of mitochondrial preparations to transfer 
erythromycin resistance, RNAse and DNAse were found to have no effect. 
In the course of this work the technique of microinjection of 
Paramecium has been developed to a state where large numbers of cells 
can be injected with relative ease. 
41. 
CHAPTER II 
A Study by B1ecn Microscopy of Transformation from Sensitivity to 
Erythromycin Resistance Following Microinjection. 
Introduction 
Paramecia collected from nature are sensitive to erythromycin; 
when they are placed in bacterized grass medium containing o.25 mg/ml 
erythromycin and incubated at 25°C, cell division is blocked after one 
or two residual fissions. However, the cells are not killed for 2-4 
weeks, but swim slowly and become black and thin. Drug resistant 
mutants have been obtained (Beale, 1969; Adoutte and Bèisson, 1971, 
1972; Beale et al. 1972), and these grow at the normal rate in 
medium containing the drug. 
When sensitive paramecia are injected with a preparation of 
mitochondria from resistant cells and these injected cells are 
placed in erythromycin containing medium, resistance to erythromycin 
usually develops within a period of between 4 and 13 days (Beale et al., 
1972; Chapter I). Before becoming completely resistant, the cells 
pass through an intermediate stage when they are pear-shaped and 
fast swimming. 
This chapter describes an investigation of the process by which 
cells, injected with mitochondria from a resistant clone, develop 
resistance to erythromycin when placed in selective medium. In 





Figure 7: Mitochondria in a sensitive cell exposed to erythromycin 
for 4 days. This shows: 
loss of cristae (compare with Fig.8) 
wavy conformation of cristae (w). 
C) flat plate like lamellae (p) parallel to the outer 
membrane. 
laminar cristae, distinguished from (c) by 
variation in the distance between the two 
component membranes. (1) 
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Figure 8: Mitochondria of aw wild type sentive cell in the 
absence of antibiotic, showing normal appearance of 
Paramecium mitochondria. These mitochondria are 
rounded or slightly elongated, with numerous curved 
tubular cristae and little matrix. 	(X 50,000). 
Figure 9; Mitochondria in a sensitive cell exposed to erythromycin 
for 6 days. This shows the greatly elongated mitochondria 
containing few cristae but several bundles of tubules 
and rigid plates. 	(X 30,000). 
42. 
on observations of whole cells, the work described here considers 
the effect of erythromycin on individual mitochondria within a cell, 
as seen by electron microscopy. 
Results 
To eliminate variation of culture conditions, all the observations 
described in this chapter were made on cells which had been grown in 
depression slides and embedded and sectioned individually. 
1. The Effect of Erythromycin on Sensitive Cells. 
After exposure of sensitive paramecium to 250 p.g/ml erythromycin, 
the following modifications of mitochondrial structure were noted, 
(Figs. 7 and 9). 
Cristae were lost progressively with time in almost all of 
the mitochondria examined when compared to untreated cells, (Fig.8). 
The remaining cristae often form a repetitive wavy structure. 
The shape and size of the mitochondria become irregular. 
In particular there is a marked reduction in the diameter and an 
increase in length of many of the mitochondria examined. 
Flat lamellae in the shape of plates of rigid appearance, 
25 nm thick, similar to those described by Newcomb et al., (1968) in 
bean root mitochondria. These rigid plates often exhibit a periodic 
structure. 
Bundles of round rod like "tubules" about 20 nm. in diameter, 
quite distinct from cristae (diameter 40 nm.). The number of tubules 
in a bundle may vary but the diameter of the tubule is constant. 
Facing page 43. 
Figure 10: Mitochondria in a resistant cell from a clone grown 
In selective medium for 9 days. These mitochondria 
are indistinguishable from those observed in 
untreated sensitive cells. 	(X 50,000). 
43. 
e) Laminar cristae are often found next to the mitochondrial 
inner membrane. These are distinguished from the flat lamellae by 
their apparent 	lower rigidity and the variability in the distance 
between the two component membranes. 
It should be noted that in almost all of these abnormal mitochondria, 
even those completely lacking cristae, both outer and inner mitochondrial 
membranes appear to persist. In addition no other cellular structure 
appears to be modified; cell cortex trychocysts and nuclei appear 
normal. The primary effects of erythromycin seem to be largely 
restricted to the mitochondrial cristae. 
These conclusions are based on the examination of 76 sections 
from 28 individual cells. 
The Effect of Erythromycin on Resistant Paramecia. 
Erythromycin at a concentration of 250 .g/ml had no observable 
effect on the resistant mutant after 6 days of growth in the drug 
(Fig.lO). The mitochondria in sections of these cells were indistinguish-
able from mitochondria in untreated paramecia (Fig.8). This conclusion 
is based on examination of 24 sections of 18 cells. 
The Effect of Erythromycin on "transforming" cells produced by 
microinjection. 
Cells which had become pearshaped and fast swimming after micro-
injection with mitochondria from the resistant strain were fixed 
approximately 24 hours before their first division. These cells were 
found to contain mitochondria of three types. 
-3 
.,. 






Figure 11: This shows the presence of two mitochondrial phenotypes 
in one cell "Resistant" (r) and send±ive (s) mito-
chondrial forms in a previously sensitive cell which 
had become "pear shaped" and fast-swimming after 13 
days in selective medium. 	(X 50,000). 
Figure 12: A section through a group of long "resistant" mito-
chondrial forms from a cell transforming to resistance 
to erythromycin after 13 days. These mitochondria may 
well be dividing rapidly. 	(X 50,000). 
Facing page 44. 
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Figure 13: An intermediate" form in a "transforming" cell 
placed in erythromycin for 13 days. This contains 
many normal cristae (c) and also a flat lamella 
niate (P) similar to those found in sensitive 
exposed to erythromycin. (Figs. 7 and 8) 
(x 75,000). 
44. 
a) Those (presumably resistant) which were apparently unaffected 
by erythromycin. These could be subdivided into two classes as 
follows: 
Mitochondria having normal dimensions similar to those 
found in resistant cells (Pigs. 10 and 1].). 
Mitochondria which appeared considerably longer than those 
found in normal cells. These often tended to occur in 
groups (Fig.12). 
b) Those mitochondria which were similar in appearance to 
mitochondria in sensitive cells exposed to 250 gg/ml erythromycin for 
more than four days. 
c) "Intermediate" forms, containing many normally developed cristae 
but also a flat lamella plate similar to those found in mitochondria of 
sensitive cells treated with erythromycin (Pig.13). These were observed 
at a very low frequency (1%). 
No other class of mitochondria was observed in these transforming 
cells. These conclusions were based on the observation of 63 sections 
of fifteen transforming cells. 
To obtain an estimate of proportions of the three mitochondrial 
types in transforming cells, entire sections from five CCils, taken 
from three separate transformation experiments were photographed and 
the different classes of mitochondria counted under a binocular 
microscope. The frequency of these different classes is shown in 
Table 6 
Facing page 45. 
Figure 14: This shows two mitochondria forms from sections of cells 
which had been injected with mitochondria and incubated 
for 6 days in erythromycin containing medium. It is 
possible that these forms are "resistant" to erythro-
mycin in view of the large number of cristae they 
contain. 	(X 50,000). 
45. 
TABLE : 	Relative Proportion of Different Types of Mitochondria 













A 394 77 22 1 
3 382 78 21 1 
C 638 73 26 1 
D 303 81 1 1 
E 184 86 13.5 0.5 
In view of the similarity in the proportions of the 3 mitochondrial 
types in the five cells studied, it is of interest to point out that these 
cells were selected on the basis of their "pear shape" and speed of movement. 
This suggests that at least 70-80% of the mitochondria must appear "resistant" 
to erythromycin before any change in cell phenotype is observed. 
A preliminary attempt was made to follow the change from erythromycin 
sensitivity to erythromycin resistance after microinjection by examining 
cells fixed 4 and 6 days after injection. Observations made on 23 cells 
proved inconclusive. Almost all the mitochondria examined appeared to be 
similar to those found in uninjected sensitive cells exposed to erythromycin. 
Pig.14 shows two mitochondria which do appear unaffected by exposure to 
erythromycin and it is possible that these are derived from the 'resistant' 
also 
mitochondria injected into the cell. However, the possibiiity/exiStS that 
these mitochondria may be part of the original sensitive population of the 
cell. 
V 
Facing page 44. 
Figure 15: A section of a sensitive cell treated with erythromycin 
for 1.2 days and then allowed to recover in non-selective 
medium. This shows the partial redevelopment of critae 
in some of these mitochondria. Some cristae appear to 
be arranged in a wavy configuration (w) similar to that 
found in mitochondria exposed to erythromycin for 4 
days (Fig.7). (X 50,000). 
46. 
It appears to be difficult to locate or distinguish the "resistant" 
mitochondria injected until the change in mitochondrial population is 
well advanced. 
4. 	The regeneration of sensitive cells exposed to erythromycin for 12 
days. 
To compare transforming cells resuming growth in selective medium 
after microinjection, with sensitive cells resuming growth in non- 
selective medium after treatment with erythromycin, 72 sensitive cells 
were placed in depressions containing selective medium for 12 days. 43 
of these died within 24 hours of transfer to non-selective medium. The 
27 surviving cells were fixed for electron microscopy after four days in 
non-selective medium. By this stage many of the cells had resumed 
active. swimming and resembled the "pear shaped" cells about to develop 
resistance after microinjection. 
Examination of sections of these regenerating cells showed that 
the mitochondria contained a very variable number of cristae (Fig.15). 
There was also a considerable reduction in the number of flat lamellae 
and bundles of round tubules compared with the mitochondria found in 
sensitive cells incubated in erythromycin for 6 days (?ig.10). However, 
other mitochondria examined, had not regained any visible internal structure. 
This may well indicate that these organelles had been permanently damaged 
by the prolonged presence of erythromycin. 
It is interesting to note that cristae were often found in a 
wavy configuration (Pig.15), similar to that observed during initial 
cristae loss produced by erythromycin. 
47. 
Thus, although cells developing erythromycin resistance and cells 
recovering in non-selective media from prolonged exposure to erythromycin 
are superficially similar in shape and behaviour, the completely different 
appearance of the mitochondria contained within these two classes of 
cells strongly suggests that the "transforming" cells do contain two 
distinct genetic types of mitochondria. 
Discussion 
1. The Effects of Erythromycin on Sensitive Cells 
The results presented in this chapter show that erythromycin has 
striking effects on mitochondria structure in sensitive cells of 
Paramecium, while the mitochondria of resistant mutants appear unaffected. 
The results are in good agreement with those of Adoutte et al. (1972) 
who studied the effects of erythromycin on resistant and sensitive 
stocks of Paramecium aurelia Syngen 4. 
It is now well established that anti-bacterial antibiotics such 
as erythromycin and chloramphenicol specifically block mitochondrial 
protein synthesis without affecting cytoplasmic protein synthesis (Mager, 
1960; Kroon, 1965; Wintersberger, 1965; Clark-Walker and Linnane, 1966; 
Firkin and Linnane, 1968; Lamb et al., 1968; Perlman and Penman, 1970). 
The inhibition of mitochondrial protein synthesis produces several 
characteristic biochemical and cytochenhical alterations in the mitochondria 
of cells exposed to these inhibitors. In yeast (Saccaromyces) Clark-
Walker and Linnane (1966) have shown that chloramphenicol causes loss 
of some cytochromes and the disoinisation of the inner mitochondrial 
membranes. Mahler et al. (1971) using shorter doses of chloramphenicol 
during respiration derepression concluded that only the synthesis of 
cytochrome Idase was affected initially. Smith-Johannsen and Gibbs 
48. 
(1970) observed loss of cristae from the mitochondria, of Ochromonas 
danica after treatment with chioramphenicol. The same phenomenon has 
also been reported in HeLa cells by Lenk and Penman (1971). In Tetra- 
hymena, chioramphenicol causes no cytochronie loss initially, but respiration 
is inhibited and the mitochondria divide to become smaller in size (Turner 
and Lloyd, 1971). 
The primary effect of erythromycin in Paramecium also appaars 
to be the inhibition of protein synthesis by mitochondrial ribosomes 
(Tait, 1972; personal communication). 
The results presented in this chapter show that one of the 
secondary effects of erythromycin on sensitive Paramecium is to cause 
large morphological abnormalities in the mitochondria. This may be 
explained in the following way. Radioactive amino acid incorporation 
studies (Roodyn et al., 1962) have shown that under appropriate 
condithns, isolated mitochondria are able to synthesize protein. 
Fractionation of mitochondria after incubation with radioactive amino 
acids has shown that incorporation occurs into the membrane protein but 
not into soluble proteins (Roodyn, 1962; Wheeldon and Lehninger, 1966; 
Haldar et al., 1966). Some authors have reported that most of the 
label is in one or two components (Birkmayer, 1971; Kadenback, 1971) 
but others have found labelled products in up to ten bands of Neurospora 
(Sebald et al., 1971; Swank et al., 1971; Wolf et al., 1971) Saccaromyces 
(Weislogel and Butow, 1970; Yang and Cripole, 1969; Thomas and Williamson, 
1971) and Tetrahymena (Chi and Suyama, 1971). 
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The variation in the number of bands is probably due to technical 
difficulties of the extraction and analysis of these hydrophcbic membrane 
proteins. Identification of the functions of these membrane proteins has 
proved difficult, but recently a component of cytochrome oxidase 
(Weiss et al., 1971) and of 	rutamycin-sentive ATPase (Tzagoloff 
and Meagher, 1971) have been shown to be synthesized on mitochondrial 
ribosomes. 
Mahler et al. (1971) have proposed that the effect of anti-
bacterial antibiotics on the structure and composition of mitochondria 
is probably due to inhibition of mitochondrial protein synthesis which 
would prevent the production of one or more proteins necessary for the 
correct assembly of functioning cristae within the mitochondria. 
According to this hypothesis, no effect would be observed initially 
in the presence of the drug. However in the absence of synthesis, 
dilution of these proteins mquired for the assembly of inner membranes 
by continued replication and normal degradation would occur. Lower 
concentrations of these "organizational" proteins would make the formation 
of normal mitochondrial membranes less and less likely. 
The observations reported in this chapter of the effects of 
erythromycin on the mitochondrial structure of Paramecium are in 
complete accord with this hypothesis, although the exact nature of the 
"organizational" protein remains to be defined. The considerable 
modifications of mitochondrial structure observed under different 
energy states (Hakenbrook, 1968, 1972; Green and Harris, 1969) and 
under different nutritional regimes (Daniels and Breyer, 1968) suggest 
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that mitochondrial membranes may well be paracrystaline in nature, in 
that different types of stable structure may form depending on the 
composition of the membrane. An alteration in the composition of 
mitochondrial membranes caused by inhibition of mitochondrial protein 
synthesis would be expected to produce new types of paracrystaline 
structure like the lamellae plates and the bundles of tubules 
described earlier in this chapter. 
ft should be pointed out that the abnormal 
physiological state of sensitive cells exposed to erythromycin or 
perhaps some indirect effect of the antibiotic on the respiratory 
chain could also produce changes in the morphology of mitochondria 
observed. However, unless the mutation to erythromycin resistance 
affects a wide range of mitochondrial functions, the finding that 
mitochondria from resistant cells are largely unaffected by 
erythromycin makes this indirect hypothesis less plausible. 
2. 	The Nature of the change of cell phenotype to erythromycin 
resistance following microinjection. 
The results presented earlier show that two mitochondrial 
phenotypes exist in one cell during transformation from erythromycin 
sensitivity to resistance. This finding strongly implies that within 
the same cell mitochondria are autonomous with respect to each other 
for erythromycin resistance. Adoutte and Beisson (1972) were able 
to show the differential elimination of one cytoplasmic marker with 
respect to the other from cells known to contain two types of mito-
chondria. They established an order of elimination which was found to 
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correspond to the temperature sensitivity of the antibiotic resistance 
markers studied. This evidence also supports the idea of initochondrial 
autonomy with respect to antibiotic resistance. 
The exact cause of the selective differential between erythro-
mycin-resistant and sensitive mitochondria in one cell is unknown. It 
was argued earlier (p.49 ) that the action of erythromycin on "sensitive" 
mitochondria was to alter the composition and properties of the inner 
mitochondriaj. membrane. The DNA of mitochondria is most probably 
closely associated with the inner membrane. If this modification of 
the inner membrane also affected the rate of replication of the 
mitochondrjaj. DNA in "sensitive" mitochondria while the rate of 
replication of mi.tochondrial DNA in "resistant" mitochondria remained 
unaffected, a cell containing both types of mitochondria would become 
populated only with "resistant" organelles when placed in 
erythromycin. 
More specifica1ly, il1imson et al. (1972) have shown that 
Saccharomyces cerevidáe :xosed to high concentrations of erythromycin 
and chioramphenicol develop a high frequency of cytoplasmic petites. 
Mitochondrial DNA was Synfisized normally during the silent pre-
mutational period, but was rapidly lost by a process partly dependant 
on degradation, at the time of the mutational event. They have inter-
preted these findings as evidence that the normal maintenance of 
mitochondrial DNA in this organism requires a specific protein or 
proteins whose assembly is inhibited by high concentration of erythromycin. 
The absence of this protein would produce a selective differential between 
"erythromycin resistant" and "erythromycin sensitive" mitochondria in 
paramecium. 
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t should be pointed out that the erythromycin concentrations 
required to induce petites are much higher than those normally used 
to select for erythromycin resistance in both yeast and paramecium. It 
is more probable that the selective differential between the two types 
of mitochondria is of a partial nature and does not involve the complete 
loss of DNA from "sensitive" mitochondria. This idea is supported by 
the observation that some mitochondria exposed to erythromycin for 12 
days can regenerate cristae when placed in drug free medium. 
It is also possible that previously 'sensitive' mitochondria 
might become 'resistant' to erythromycin by acquiring part or all of 
a genome conferring resistance from one of the "resistant" mitochondria 
injected into the cell. The occurrence of low numbers Of 
mitochondria observed in transforming cells does not conflict with 
this hypothesis. 
To examine the possibility that the modifications of mitochondria 
structure observed in transforming cells were due to the abnormal 
physiological conditions in the cell, sensitive Paramecia were 
exposed to erythromycin and then allowed to recover in non-selective 
media. Cells recovering from this long dose of erythromycin were 
similar in external appearance to cells transforming to resistance 
following microinjection. However, in marked contrast to the two 
major classes of mitochondria found in transforming cells, the 
regenerating cells were found to contain a wide range of mitochondria 
in different stages of regeneration (or degeneration). 
It is therefore most likely that the presence of three different 
classes of mitochondria obved in transforming cells is correlated 
with the presence of at least two genetically different types of 
organelle. 
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In summary, results reported here show firstly that erythromycin 
has striking effects on mitochondrial structure in sensitive cells of 
Paramecium, and secondly that in cells transforming to erythromycin 
resistance following microinjection, two mitochondrial phenotypes can 
be observed within the same cell. 
These findings have been interpreted as evidence that transformation 
of cell phenotype to erythromycin resistance occurs through the process 
of differential replication of the injected "resistant" mitochondria, 
With respect to the original population of "sensitive" organelles. 
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CHAPTER III 
The transfer of mitochondria between syngens 
Introduction 
The technique of inicroinjection of sensitive cells with preparations 
of mitochondria from resistant cells, described in Chapter I allows 
the transfer of aitochondria between genetically isolated syngens and 
species of Paramecium. This approach makes possible investigation 
of two important aspects of witochondrial genetics. Firstly, information 
concerning the ability of erythromycin-resistant mitochondria from one 
eyngen to replicate in the nucleo-cytoplasiniC system of another can be 
obtained. Secondly, the genetic basis of intersynen aitochondrial 
protein differences can be studied. 
This chapter describes results concerning the interactions between 
the nucleus and mitochondria of different syngens and the use of inter-
syngenic variation to determine the inheritance of the mitochondrial 
enzyme fumarase. 
Results 
L. 	Variation in the successful transfer of mitochondria between 
different syngens. 
When erythromycin resistance was transferred from one syngen to 
another by microinjection of mitochondria prepared from erythromycin-
resistant stocks, two classes of result were observed. These were 
denoted "High" and "Low" efficiency transfers. 
TABLE 7: 
Efficiency of Transfer of Erythromycin Resistance between Syngens 
(i) High Efficiency Transfer 	Inter-syngen Transfer 	 Intra-syngen Transfer (controls) 
No.of cells No. No.of cells No. 
Donor Recipient developing surviving % transfer developing surviving % transfer 
Expt.No. Stock Stock resistance injection of resistance resistance injection of resistance 
14 
5 E l 18 18 100% 7 9 78% 
21 9 29 
5 L 32 57 56% 27 33 82% 
Hybrid 
cells 




19 26 73% 15 16 94% 
(ii) Low .iIficiency Transfer 
2 40 5% 12 14 85% 1, 	11 l 7 ELI 
21, 	4, 	6 
1 E 5 EIS 4 49 870 13 20 65% 
1 E 3 ELI 0 16 - 13 13 100% 
16 
1 B 14E5 
0 20 - 3 3 (100%) 





 ml 7 1 42 2% 15 20 75% 
17 1Ml5 5 1 22 2% 5 7 7076 
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"High" Efficiency transfers were defined as those transfers where 
more than half of the cells injected acquired erythromycin resistance. 
This category includes all intra-syngen transfers studied and some inter-
syngen transfers. Table 7 (i) shows the intersyngen transfers where 
at least 50% of the cells injected developed resistance to erythromycin 
after selection. The time taken for both inter- and intra-syngen cells 
to develop resistance was the same in these "high" efficiency transfers; 
about 5 to 6 days. The erythromycin resistance acquired in inter-
syngen transfers in these experiments was found to be stable in non-
selective medium for at least one year. 
"Low" Efficiency transfers were defined as those transfers where 
less than 10% of the cells injected acquired erythromycin resistance. 
None of the intra-synen and only some of the intersyngen transfers 
fell into this category. Table 7 (ii) shows heterosyngen transfers where 
the number of cells developing resistance to erythromycin is less than 
1076 of the total number of cells surviving injection. In contrast, the 
intra-syngen control transfers injected with the same mitochondrial 
preparathn always give 65-100% development of resistance. 
The erythromycin resistance acquired in "low" efficiency inter- 
syngen transfers is also stable for at least one year in non-selective 
media and these cells appear to grow at the normal rate of 3-4 fissions 
per day, in selective medium. However the time taken to acquire resistance 
by intersyngen transfer is very much longer (12-29 days) than the time 
taken by intra-syngen controls (5-6 days) injected in the same experiment, 
with the same preparation of mitochondria. 
These results show that it is possible to transfer erythromycin 
resistance between genetically isolated groups of Paramecium by injection 







Figure 16. Mitochonth'ial Transfers Between Syngens 1 and 5. 
* 	49 
- No. of cells developing resistance. 
Total No. of cells injected. 
(for explanation see text) 
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only achieved between syngens 1, 5 and 7 (see Table 7 ). These syngens 
show morphological and physiological similarities and are considered 
to be closely related taxonomically. These results do not exclude 
the possibility that mitochondrial transfer between other syngens 
and other species of paramecium may be carried out. 
All the intersyngen transfer results obtained are shorn in 
Table 7 . 	However, two particular combinations of results will now 
be considered in more detail to show more clearly the interesting 
features of this work. 
2. 	Reciprocal transfer between syngens _l and 5. 
Figure 16 shows the proportion of cells acquiring erychromycin 
resistance following microinjection with mitochondria originally 
derived from syngen 1, stock 168 ERl, and then transferred successively 
between syngens 1 and 5. The intra-syngen control experiments are not 
shown. There are two important features of these results. 
Ci) 	Transfers from syngen 1, stock 168, to syngen 5, occur with "low" 
efficiency, and transfers from syngen 5 to syngen 1 occur with "high" 
efficiency. 
(ii) Mitochondria prepared from 5 ER 
ml give "high" efficiency of 
transfer when injected directly into syngen 5 intra-syngen control 
(not shown) 
cells/ The same mitochondria give "low" efficiency of transfer when 
injected into syngen 5 cells after a further passage through syngen 1. 
These observations suggest that mitochondria may be modified 
by growth in syngen 1 cells in such a way that their ability to 





Figure 17.  Mitochonth'ial Transfers Between Syngens 1, S and 7. 
* 2/ - No. of cells developing resistance. 
Total No. of cells injected. 
(For explanation see. text) 
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3. 	Transfer of Erythromycin resistance from syngens 1: ,And 5 to 
syngen 7. 
Figure 17 shows the proportion of syngen 7 cells acquiring 
erythromycin resistance following microinjection with mitochondria 
prepared from the erythromycin resistant stocks 5RR1 and 5 ER 
ml
is a 
"hybrid" stock containing erythromycin resistant mitochondria derived 
from stock 168 ER1 , syngen 1 by microinjection. There are again 
two important features to be noted. 
Erythromycin is transferred with "high" efficiency from 5 ER 
to 7 ES. 
Erythromycin resistance is transferred with "low" efficiency 
from 5 ERmitO  7 ES and also from 1 ER(1681) to 7 ES. 
These findings show that in this set of experiments the "low" 
efficiency transfer of erythromycin resistance from 5 BR 1 
 to 7 ES 
is probably caused by some mitochondrially inherited character of 
stock 1(168) ER  which is not modified by growth in syngen 5 cells. 
4. 	The Genetic Control of the Mitochondrial Enzyme Fumarase 
Syngen 7 sensitive cells were microinjected with mitochondria 
prepared from syngen 1 erythromycin resistant cells and after 21 days 
incubation in selective medium, 2 out of a total of 40 microinjected 
syngen 7 sensitive cells became resistant (Table 7)• The transfer of 
erythromycin resistance implies that the mitochondrial genone of syngen 
1 may be introduced and replicated in a cell containing a syngen 7 
nucleus. This "hybrid" cell may be used to locate the genetic information 
coding for any character which shows variation between the two 'parental" 
stocks (see Fig.18). 	(overleaf). 











Figure 18. Transfer of mitochondria by micro-injection between different 





7 	1/7 	1 	syngen 	7 	1/7 	1 
Figure 19. Starch gel zymogram of funarase, showing electrophoresis 
of extracts from syngen 1 (168E), syngen 7 (227) and syngen 7 cells 
micro-injected with syngen 1 erythromycin resistant mitochondria (7/1). 
Electrophoresis was carried out for 3 hours at 0°C in a 0.01 M phosphate-
citrate buffer pH = 5.5. Enzyme activity was localised by overlaying 
the gel with 30 mis of staining solution (3.9 mg/ml sodium fumarate, 0.25 mg/Ml 
NAD, 0.2 mg/ml, NTT-tetrazoliuni, 0.02 mg/ml P145 and 1 i.u. maiic dehydrogenase 
in 0.1 14 phosphate buffer pH = 7.4) and incubating at 35°C. 
5o.  
It is known that syngens 1 and 7 differ with regard to the 
electrophoretic mobility of their mitochondrial fumerasL(Tait, 1970). 
Extracts from cells of stocks 1 ER, 7 ES (parental) and 7 LR 
(hybrid) were made and characterised by starch gel electrophoreis. 
Fig.19 hows the bands of fumarase activity from these stocks. The 
hybrid 7 ER  I shows a band of fumarase activity identical in 
mobility with that shown by 7 ES and different from that shown by 
1 ER. 
The result shows that fumerase is not controlled by the syngen 1 
erythromycin resistant mitochondrial genome and by inference must be 
controlled by the syngen 7 nuclear genome. 
Discussion 
1. Variation in Efficiency 	Resistance Transfer 
Results have been presented which show that, in some intersyngen 
transfers, erythromycin resistance is transferred to only a small 
proportion of those cells injected. Most of the intra-syngen cells 
injectedvith the same preparation of mitochondria do develop 
resistance. In addition, the intersyngen cells take coni'erably 
loner to develop resistance than do intra-syngen cells. A priori, it might 
be argued 	that mitochondria could behave in two ways after transfer 
to a new tock. Either the introduced organelles are able to 
replicate in the new stock or, because of some genetic incompatability 
with the strange nuclear products, they are not. 
However, these results suggest that, in some cases, more complex 
processes determine whether an introduced mitochondria will gvow 
within the cytoplasm of a foreign syngen. While the nature of these 
complex processes is still obscure, it is clear that nuclear and 
mitochondrially inherited factors can cause "low" efficiency transfer 
of mitochondria between syngens. Consideration of reciprocal transfers 
of erythromycin resistance between syngens 1 and 5 has: shown that 
replication of mitochondria in syngen 1 (168) modifiesthee 
mitochondria in such a way that "low" efficiency tranfer is observed 
on retransfer to syngen 5. This modification causing low efficiency 
transfer could take at least three forms. 
It is possible that the mitochondrial DNA is modified in some 
way by enzymes of the host cell. This system might be analogous with 
the modification and restriction system well documented in bacterial 
systems (Arber, 1971). "Low" efficiency transfers could be caused 
by the degradation of the unmodified introduced DNA by "host" restriction 
enzymes. There would be a finite probability that an introduced geome 
might be modified before restriction, in which case the "host" cell 
could become erythromycin resistant by replication of the newly 
modified DNA conferring resistance. 
It is possible that the structure of a mitochondria from one 
syngen may be "incompatible" in some way with the nuclear cytoplasmic 
systems of another syngen. No replication of the newly introduced 
mitochondria could occur until the "incompatable" units had been 
replaced by a new paracrystaline structure. Once the introduced 
genome conferring resistance was associated with a structure 
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compatable with the mitochondrial systems of the host cell, replication 
of this genome could occur. 
(iii) 	Recombination between the introduced DNA and the host 
mitochondrial DNA is another possibility. However, the results under 
discussion are unlikely to be explained by recombination as this 
requires the rate of mitochondrial recombination ID be very much 
higher in syngen 1 than in syngen 5. This seems to be unlikely. 
Furthermore repeated attempts to obtain recombination between 
erythromycin and chioramphenicol resistance markers in syngen 1 
(Beale et al, 1972) and syngen 4 (Adoutte and Beisson, 1972) have 
failed to produce any convincing results. 
However, it is not yet possible to decide between modification 
of the mitochondrial DNA itself and modification or ren1cenient 
of elements of the mitochondrial structure as an explanation of these 
findings. 
Consideration of the results of transferring two different 
classes of mitochondria from syngen 5 to syngen 7 has shown that in 
some cases a mitochondrially inherited character can cause "low" 
efficiency transfer between syngens. This character is likely to 
be of at least one of two basic types. 
(i) 	It could be a physical site on the mitochondrial DNA related 
to the replication of physiological functions of the organelle. 
Before the introduced resistant genonie could be expressed, a new 
type of interaction between this DNA and the host mitochondrial 
system would have to occur. This might involve the formation of a 
new paracrystaline structure "compatible" with the attachment sites 
on the DNA. 
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(ii) 	 Alternatively, any one of the products of mitochondrial DNA 
which interact with the "host" mitochondrial components to form a self 
organising aracrystaline structure could cause the mitochondrially 
inhibited "low" efficiency transfer. In order for the introduced 
mitochondria to replicate, a new self-organising structure "compatible" 
with the "host" mitochondrial compoents must occur. 
Any explanation of "low" efficiency of transfer must account for 
the process by which mitochondria acquire the ability to replicate 
in a cell in which they were previously unable to grow. This ability 
to replicate is not lost until the mitochondria are retransferred 
into a cell of another syngen. Much of the current thought concerning 
the structure of organelle membranes evokes the concept of para-
crystaline structures whose nature and composition is determined 
in part by the pre-existing structure (Green et al. 1971; Benson et 
al., 1971; Mahler et al., 1971). A paracrystaline structure has the 
property of being able to "switch" from one stable form to another 
stable form in the manner required to explain the phenomenon of "low" 
efficiency transfer. Certainly, the evidence presented in this 
chapter does not conflict with the hypothesis that some mitochondrial 
characters may be determined by pre-existing epigenetic structures 
not only by the nuclear and mitochondrial DNAs. 
2. 	The Genetic Control of the mitochondrial enzyme fumarase 
Certain soluble mitochondria enzymes have been shown to be 
controlled b/ nuclear genes in both Paramecium (Tati, 1968, 1970) 
and other organisms (Munkres et al., 1965; Munkres and Woodward, 
1967; Davidson and Coiter, 1967; Longo and Scandalios, 1969; 
Davidson et al., 1970) using within-species genetic analysis. The 
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observations presented in part 2 of the results provide further 
evidence for the idea that all the soluble mitochondrial enzymes 
are controlled by the nuclear genome. Because intra-syngen variation 
of fumerase with respect to electrophoretic mobility has not been 
found, intersyngenic hybrid cells produced by microinjection were 
used to determine the nature of the genetic control of fumerase. 
The results presented strongly suggest that fumerase is coded for 
by the nuclear genome. 
In summary, the results obtained so far show two classes 
of interaction causing "low" efficiency transfer. One class, 
illustrated by reciprocal transfer between syngens 1 and 5, is 
caused by a modification of the mitochondria by the nucleus such 
that the organelle becomes altered in its ability to transmit 
erythromycin resistance following injection. 
The second class of interaction illustrated by 
transfers between 1, 5 and 7 shows that the origin of the initochonddal 
genome is also important in controlling transmission or erythromycin 
resistance from one syngen to another. By analysis of intersyngen 
"hybrid" cells it has been shown that the mitochondrial enzyme 
fumerase is coded for by nuclear genes. 
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GENERAL O)NCLUS ION AND PROS? I3Cl 
The technique of microinjection has often proved a useful 
way of investigating the biology of the cell and its components. The 
work described in this study uses the technique of microinjection to 
investigate directly features of mitochondrial genetics in Paramecium 
aurelia. Initially this technique was used to show that erythromycin 
resistance was located in the mitochondria and that acquisition of 
erythromycin resistance by a sensitive cell after microinjection was 
the result of selection for the erythromycin resistant mitochondria 
introduced. 
Perhaps the most important advantage of microinjection is 
that it makes possible transfer of mitochondria across natural 
genetic barriers. This has two important consequences. Firstly, 
it allows investigation of the ability of mitochondria of one syngen 
to grow in the cytoplasm of other syngens. From this type of work 
both nuclear and mitochondrial factors have been found to modify the 
way in which mitochondria behave after transfer to a different syngen. 
In addition, some evidence was found to support the idea that the 
pre-existing organization of the mitochondrial components also 
affected the ability of mitochondria to grow in cells of a different 
syngen. Secondly, it allows the production of a cell containing the 
mitochondria of one syngen and the nucleus of another. 
The exact nature and function of the proteins coded by the 
mitochondrial DNA still remains one of the greatest problems in 
mitochondriai. genetics. As stated earlier, the definitive 
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most probably 
identification of a protein coded by the mitochondrial DNAfrequires 
the correlation of changes in the mitochondrial DNA with changes in 
that protein. There are three possible approaches to this problem 
The study of proteins altered by cytoplasmic mutations. The 
results so far obtained by this approach have proved equivocal. In 
Paramecium, Beale et al (1971) have reported that cytoplasmic 
erythromycin-resistance altered the protein composition of mito-
chondrial ribosomeç but the nature of this alteration has proved 
difficult to define. Similar results were obtained in yeast, 
but further investigation showed that this apparent ribosomal 
protein difference might have been an artefact caused by the 
techniques used (Borst, private communication). 
The study of mitochondrial proteins showing maternal 
inheritance. Dawi.d (1972) has shown by hybridization studies that 
mitochondrial DNA is maternally inherited in crosses between two 
species of Xenopus. However, any demonstration that a protein is 
coded for by the mitochondrial DNA would require extensive back 
crossing to the parental species, a procedure made difficult by the 
partial or total sterility of this inter-species hybrid. 
The study of artificially produced "hybrid" cells containing 
the mitochondria of one species and the nucleus of another. The 
production of this type of cell by microinjection has been 
discussed at length in this study. It is known that many soluble 
mitochondrial enzymes vary between syngens (Tait, 1968, 1970a/b) and 
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there is no reason to suppose that insoluble initochondrial proteins 
do not vary in the same way. The careful analysis of the 
products of mitochoddrial protein synthesis by disc-gel and 
immuno-electrophoresis should allow identification of those proteins 
which vary between syngens. Similar analysis of the mitochondrial 
protein of the "hybrid" cell would allow the location of the 
information coding for the variant protein in either the mitochondrial 
or the nuclear genorne. 
The techniques just described will be exploited in the 
future in an attempt to identify proteins coded by the mitochondrial 
DNA. It is now evident that only by the simultaneous use of the 
techniques both of genetics and biochemistry will the fascinating 
problems of mitochondrial genetics be solved. 
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Two mitocliondrial phenotypes in single paramecium cell 223 
Observations on two mitochondrial pheno-
types in single paramecium cells 
J. K. C. KNOWLES. Institute of Animal Genetics, 
University of Edinburgh, Edinburgh EH9 3JN, Scot- 
land 
In yeast, evidence has been published [1, 2] 
indicating that resistance to erythromycin 
and chloramphenicol is controlled by mito-
chondrial DNA, and in Paramecium aurelia 
Beale et al. [3] and Adoutte & Beisson [4] 
have also shown that resistance to the same 
drugs is controlled by extranuclear genetic 
factors, most probably located within the 
mitochondria. These genetical studies have 
all been based on observations on the be-
haviour of whole cells. In the work to be 
described here, the effect of erythromycin on 
individual mitochondria as seen by electron 
microscopy will be considered. 
Paramecia collected from nature are sensi-
tive to erythromycin, i.e. when they are 
placed in bacterized grass medium [5] con-
taining the drug at a concentration of 0.25 
mg/ml, and incubated at 25CC, cell division 
is blocked after one or two residual fissions. 
However, the organisms are not killed for 
some 2 to 4 weeks, but swim slowly and 
become black and thin. Drug-resistant mutants 
have been obtained [3, 4] and these grow and 
Exptl Cell Res 70 
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Table 1. Relative proportions of the different 
types of in itochonc/ria in transforming cells 
Total of 
mito- Mitochondrial types 
chondrial 
sections % "inter- 
Cell counted resistant 	sensitive mediate" 
A 394 77 	22 
B 382 78 21 
C 638 73 	26 
D 303 81 18 1 
E 184 86 	13.5 0.5 
cells, entire sections from five cells, taken 
from three separate transformation experi-
ments, were photographed and the counts 
from these photographs are shown in table 1. 
In view of the similarity in the proportions 
of the three mitochondrial types in the five 
cells, it is of interest to point out that these 
were all selected on the basis of their pear-
shape and speed of movement of the para-
mecia, from which it was concluded that 
they were in the process of transforming 
from the sensitive to the resistant state. 
The main conclusion from these provi-
sional observations, based on study of single 
cells, is that within a single paramecium two 
(and often three) types of mitochondria can co-
exist in a common cytoplasmic environment, 
thus strengthening the hypothesis that mito-
chondria have a partial genetic autonomy. 
Thanks are expressed to Dr A. Jurand for his valuable 
advice. 
The author is a MRC Post-Graduate Research 
Student. 
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